dcid	dc_name	dc_sourcetype	fdid	fd_name	md_name	maxphase
DC00001	2141-V11;D2C7IT	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00002	AB248;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00002	AB248;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC00002	AB248;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00002	AB248;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00003	ABBV011;Budigalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00004	ABBV514;Budigalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00005	Abemaciclib;Anastrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC00006	Abemaciclib;Anastrozole;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00007	Abemaciclib;Anastrozole;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00008	Abemaciclib;Anastrozole;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00008	Abemaciclib;Anastrozole;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00009	Abemaciclib;Atezolizumab	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00010	Abemaciclib;Atezolizumab;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00011	Abemaciclib;Atezolizumab;Giredestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00012	Abemaciclib;Belzutifan	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC00013	Abemaciclib;Bicalutamide	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00014	Abemaciclib;Crenigacestat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00014	Abemaciclib;Crenigacestat	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00014	Abemaciclib;Crenigacestat	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00015	Abemaciclib;Elacestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00016	Abemaciclib;Everolimus;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00017	Abemaciclib;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00018	Abemaciclib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC00018	Abemaciclib;Fulvestrant	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00018	Abemaciclib;Fulvestrant	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00019	Abemaciclib;Fulvestrant;Samotolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00020	Abemaciclib;Fulvestrant;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00021	Abemaciclib;Giredestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00022	Abemaciclib;Letrozole	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00023	Abemaciclib;Letrozole;Samotolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00023	Abemaciclib;Letrozole;Samotolisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00023	Abemaciclib;Letrozole;Samotolisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00024	Abemaciclib;Lodapolimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00024	Abemaciclib;Lodapolimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00024	Abemaciclib;Lodapolimab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00025	Abemaciclib;LY3499446	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00026	Abemaciclib;Necitumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00027	Abemaciclib;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00028	Abemaciclib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00029	Abemaciclib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00029	Abemaciclib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00029	Abemaciclib;Pembrolizumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00030	Abemaciclib;Ramucirumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00030	Abemaciclib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00030	Abemaciclib;Ramucirumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00031	Abemaciclib;Samotolisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00031	Abemaciclib;Samotolisib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00032	Abemaciclib;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC00033	Abemaciclib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC00034	Abemaciclib;Temuterkib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00034	Abemaciclib;Temuterkib	DrugComb	FD00017	Glioma	Glioma	Early Phase 1
DC00034	Abemaciclib;Temuterkib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00034	Abemaciclib;Temuterkib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00034	Abemaciclib;Temuterkib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00035	Abemaciclib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00036	Abemaciclib;Trastuzumab;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00037	Abemaciclib;Vepdegestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00038	Abemaciclib;Xentuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00038	Abemaciclib;Xentuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00039	Abemaciclib;ZN-c5	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00040	Abequolixron;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00041	Abequolixron;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00042	Abexinostat;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00043	Abiraterone;Abivertinib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00044	Abiraterone;Apalutamide;Goserelin	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00045	Abiraterone;Cabozantinib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00046	Abiraterone;Capivasertib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 3
DC00047	Abiraterone;Carotuximab	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00048	Abiraterone;Imaradenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00049	Abiraterone;Ipatasertib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 3
DC00049	Abiraterone;Ipatasertib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00050	Abiraterone;Niraparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Approval
DC00051	Abiraterone;Olaparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Approval
DC00052	Abiraterone;Onapristone	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00053	Abiraterone;Tildrakizumab	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00054	Abiraterone;TQB3823	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00055	ABM1310;Cobimetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00056	Acalabrutinib;Ceralasertib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00057	Acalabrutinib;Durvalumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00058	Acalabrutinib;Magrolimab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00059	Acalabrutinib;Navtemadlin	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00059	Acalabrutinib;Navtemadlin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00060	Acalabrutinib;Obinutuzumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00060	Acalabrutinib;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00061	Acalabrutinib;Obinutuzumab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00061	Acalabrutinib;Obinutuzumab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00062	Acalabrutinib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00062	Acalabrutinib;Pembrolizumab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC00062	Acalabrutinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00063	Acalabrutinib;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00064	Acalabrutinib;Ublituximab;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00065	Acalabrutinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2|Phase 3
DC00065	Acalabrutinib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00066	Acalabrutinib;Vistusertib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00067	Acasunlimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00068	Acimtamig;Pembrolizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00069	Acitretin;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00070	ACP319;Acalabrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00070	ACP319;Acalabrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00071	Adagrasib;Afatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00072	Adagrasib;Avutometinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00073	Adagrasib;Batoprotafib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00074	Adagrasib;BI1701963	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00075	Adagrasib;Cetuximab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00076	Adagrasib;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00077	Adagrasib;MRTX0902	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00078	Adagrasib;Nab-sirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00079	Adagrasib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00080	Adagrasib;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00081	Adagrasib;Palbociclib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00082	Adagrasib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00083	Adavosertib;Durvalumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00084	Adebrelimab;Fuzuloparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00085	Adebrelimab;Trastuzumab Rezetecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00086	ADG106;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00087	AEE788;Everolimus	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00088	Afatinib;Afatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00089	Afatinib;Becotatug	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC00089	Afatinib;Becotatug	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00090	Afatinib;Cetuximab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00091	Afatinib;Dasatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00092	Afatinib;Intetumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00093	Afatinib;Necitumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00094	Afatinib;Nimotuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00095	Afatinib;Nintedanib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00096	Afatinib;Palbociclib	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC00096	Afatinib;Palbociclib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00097	Afatinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00098	Afatinib;Ruxolitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00099	Afatinib;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00100	Afatinib;Sirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00101	Afatinib;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00102	Afatinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00103	Afatinib;Xentuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00104	Afatinib;XH30002	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC00105	Afuresertib;Carfilzomib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00106	Afuresertib;Trametinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00106	Afuresertib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00107	Agatolimod;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00108	Agatolimod;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00109	AGEN2373;Botensilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00110	AK127;Cadonilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Early Phase 1
DC00110	AK127;Cadonilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Early Phase 1
DC00111	AL2846;Benmelstobart	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00112	Aldesleukin;Bevacizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00113	Aldesleukin;Interferon alfa-2b;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00114	Aldesleukin;Ipilimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00115	Aldesleukin;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00115	Aldesleukin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Early Phase 1
DC00115	Aldesleukin;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00116	Aldesleukin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00117	Aldesleukin;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00118	Aldesleukin;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00119	Alectinib;Atezolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00120	Alectinib;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00121	Alectinib;Cobimetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00122	Alectinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00123	Alemtuzumab;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00124	Alextatug;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00125	Alflutinib;Anlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00126	Alflutinib;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00127	Alflutinib;Disitamab Vedotin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00128	Alflutinib;Ifebemtinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00129	Alflutinib;RC108	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00130	Alflutinib;RC108;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00131	Alirocumab;Cemiplimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00132	Alisertib;Brentuximab Vedotin	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC00133	Alisertib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00134	Alisertib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00135	Alisertib;Pazopanib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00136	Alisertib;Sapanisertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00136	Alisertib;Sapanisertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00137	Alisertib;Serabelisib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00138	Alisertib;Tovorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00139	Allitinib;Anlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00140	Alobresib;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00141	Alobresib;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00142	Alobresib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00143	Alomfilimab;Atezolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00144	Alpelisib;Binimetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00145	Alpelisib;Cetuximab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00146	Alpelisib;Cetuximab;Encorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00147	Alpelisib;Enzalutamide	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00148	Alpelisib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC00149	Alpelisib;Fulvestrant;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00150	Alpelisib;Ganitumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00151	Alpelisib;Infigratinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00152	Alpelisib;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00153	Alpelisib;Letrozole;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00154	Alpelisib;LGH447	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00155	Alpelisib;Luminespib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00156	Alpelisib;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 3
DC00157	Alpelisib;Pertuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00158	Alpelisib;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00159	Alpelisib;Sotrastaurin Acetate	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00160	Alpelisib;Tipifarnib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00161	Alrizomadlin;Lisaftoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00161	Alrizomadlin;Lisaftoclax	DrugComb	FD00031	Neuroblastoma	Other Cancer	Phase 1
DC00162	Alrizomadlin;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00163	Alrizomadlin;Toripalimab	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC00164	ALT803;Atezolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00165	ALT803;Atezolizumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00166	ALT803;Avelumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00167	ALT803;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00168	ALT803;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00169	ALT803;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00170	Alvocidib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00171	Amcasertib;Napabucasin	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00172	Amcasertib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00173	Ametinib;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00174	AMG193;IDE397	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00175	AMG820;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00176	Amivantamab;Bevacizumab;Lazertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00177	Amivantamab;Capmatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00178	Amivantamab;Cetrelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00179	Amivantamab;Lazertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00180	Amivantamab;Tepotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00181	AMX-818;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00182	Anastrozole;Bevacizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00183	Anastrozole;Durvalumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00184	Anastrozole;Entinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00185	Anastrozole;Erlotinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00186	Anastrozole;Everolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00187	Anastrozole;Everolimus;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00188	Anastrozole;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00189	Anastrozole;Gefitinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00190	Anastrozole;Goserelin	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00191	Anastrozole;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00192	Anastrozole;Saracatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00193	Anastrozole;Sorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00194	Anastrozole;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00195	Anastrozole;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00196	Anastrozole;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00197	Anastrozole;Tretinoin	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00198	Anastrozole;Vandetanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00199	Anastrozole;Vistusertib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00200	Anastrozole;XZP3287	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00201	Anbenitamab;Erfonrilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00201	Anbenitamab;Erfonrilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00201	Anbenitamab;Erfonrilimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00202	Andecaliximab;Nivolumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00203	Anetumab Ravtansine;Atezolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00204	Anlotinib;Aumolertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00205	Anlotinib;Benmelstobart	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00206	Anlotinib;BR790	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00207	Anlotinib;Cadonilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00208	Anlotinib;Camrelizumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC00209	Anlotinib;Dacomitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00210	Anlotinib;Everolimus	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00211	Anlotinib;Fuzuloparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00212	Anlotinib;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00213	Anlotinib;Icotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00214	Anlotinib;JNJ64794964	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00215	Anlotinib;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00216	Anlotinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00217	Anlotinib;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00218	Anlotinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00219	Anlotinib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00219	Anlotinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00220	Anlotinib;Penpulimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00220	Anlotinib;Penpulimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00220	Anlotinib;Penpulimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00221	Anlotinib;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00222	Anlotinib;Sunvozertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00223	Anlotinib;Tislelizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00223	Anlotinib;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00223	Anlotinib;Tislelizumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00224	Anlotinib;Toripalimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00224	Anlotinib;Toripalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00224	Anlotinib;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00225	Anlotinib;TQB2858	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00226	Anlotinib;TQB3616	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00227	Anlotinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00228	ANV419;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00229	Anvatabart Opadotin;Pyrotinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2|Phase 3
DC00230	Apalutamide;Carotuximab	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00231	Apalutamide;Degarelix	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00232	Apitolisib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00233	Apolizumab;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00233	Apolizumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00234	ARRY382;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00235	Asciminib;Imatinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00236	Asciminib;Nilotinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00237	Ascrinvacumab;Regorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00238	ASP1570;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00239	ASP1951;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00240	ASP8374;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00241	Asparaginase;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Early Phase 1
DC00242	AT7519M;Bortezomib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00243	Atamparib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00244	Atezolizumab;BDB001	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00245	Atezolizumab;Bempegaldesleukin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Approval
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00246	Atezolizumab;Bevacizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00247	Atezolizumab;Bevacizumab;Cobimetinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00248	Atezolizumab;Bevacizumab;Ipatasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00249	Atezolizumab;Bevacizumab;Selicrelumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00249	Atezolizumab;Bevacizumab;Selicrelumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00250	Atezolizumab;Bevacizumab;Tiragolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00250	Atezolizumab;Bevacizumab;Tiragolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00251	Atezolizumab;Bevacizumab;Tocilizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00252	Atezolizumab;Bevacizumab;TTI101	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00253	Atezolizumab;Bomedemstat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00254	Atezolizumab;Cabozantinib	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00254	Atezolizumab;Cabozantinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00254	Atezolizumab;Cabozantinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00254	Atezolizumab;Cabozantinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00255	Atezolizumab;Camonsertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00256	Atezolizumab;Cibisatamab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00256	Atezolizumab;Cibisatamab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00257	Atezolizumab;Ciforadenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 3
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC00258	Atezolizumab;Cobimetinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC00259	Atezolizumab;Cobimetinib;Vemurafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00259	Atezolizumab;Cobimetinib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00260	Atezolizumab;D2C7IT	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC00261	Atezolizumab;Daratumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00262	Atezolizumab;Divarasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00263	Atezolizumab;DSP107	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00263	Atezolizumab;DSP107	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00264	Atezolizumab;Eciskafusp Alfa	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00265	Atezolizumab;Efineptakin Alfa	DrugComb	FD00012	Cutaneous Squamous Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC00265	Atezolizumab;Efineptakin Alfa	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00265	Atezolizumab;Efineptakin Alfa	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00265	Atezolizumab;Efineptakin Alfa	DrugComb	FD00028	Merkel Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC00266	Atezolizumab;Emactuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00266	Atezolizumab;Emactuzumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00267	Atezolizumab;Emactuzumab;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00268	Atezolizumab;Enfortumab Vedotin	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00269	Atezolizumab;Entinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00270	Atezolizumab;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 3
DC00271	Atezolizumab;Epacadostat	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00271	Atezolizumab;Epacadostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00272	Atezolizumab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00273	Atezolizumab;Etrumadenant;Regorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00274	Atezolizumab;Evolocumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00275	Atezolizumab;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00276	Atezolizumab;Fulvestrant;Ipatasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00277	Atezolizumab;GB1211	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00278	Atezolizumab;Gilteritinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00279	Atezolizumab;Giredestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00280	Atezolizumab;Idasanutlin	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00280	Atezolizumab;Idasanutlin	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00281	Atezolizumab;Imatinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00282	Atezolizumab;Inobrodib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00283	Atezolizumab;Ipatasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00283	Atezolizumab;Ipatasertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00284	Atezolizumab;Isatuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00285	Atezolizumab;KF0210	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00286	Atezolizumab;Ladiratuzumab Vedotin	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00287	Atezolizumab;Lenvatinib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC00288	Atezolizumab;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Early Phase 1
DC00289	Atezolizumab;Linagliptin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00290	Atezolizumab;Lirilumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00291	Atezolizumab;Lirilumab;Obinutuzumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00292	Atezolizumab;Magrolimab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00292	Atezolizumab;Magrolimab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00293	Atezolizumab;Motixafortide	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC00293	Atezolizumab;Motixafortide	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00293	Atezolizumab;Motixafortide	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00293	Atezolizumab;Motixafortide	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC00294	Atezolizumab;Niraparib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00295	Atezolizumab;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00296	Atezolizumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00297	Atezolizumab;Regorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00298	Atezolizumab;RO6870810	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00298	Atezolizumab;RO6870810	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00299	Atezolizumab;RO7300490	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00300	Atezolizumab;RO7496353	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00301	Atezolizumab;Rociletinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00302	Atezolizumab;Rogaratinib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00303	Atezolizumab;Rucaparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00303	Atezolizumab;Rucaparib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00304	Atezolizumab;Sacituzumab Govitecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00305	Atezolizumab;SB11285	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00305	Atezolizumab;SB11285	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00306	Atezolizumab;Selicrelumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00306	Atezolizumab;Selicrelumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00307	Atezolizumab;Simlukafusp Alfa	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00308	Atezolizumab;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00309	Atezolizumab;Tazemetostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00310	Atezolizumab;Tinengotinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00311	Atezolizumab;Tiragolumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00312	Atezolizumab;Tivozanib	DrugComb	FD00043	Vulvar Cancer	Other Cancer	Phase 1|Phase 2
DC00313	Atezolizumab;Tocilizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00313	Atezolizumab;Tocilizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00314	Atezolizumab;Trabedersen	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00315	Atezolizumab;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00315	Atezolizumab;Trastuzumab Emtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00316	Atezolizumab;Uliledlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00316	Atezolizumab;Uliledlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00316	Atezolizumab;Uliledlimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00317	Atezolizumab;Varlilumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00318	Atezolizumab;Vidutolimod	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00319	Atezolizumab;Vismodegib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00320	Atezolizumab;Vonlerolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00321	Atezolizumab;Vopikitug	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00322	Atezolizumab;Vorolanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00323	Atezolizumab;XmAb24306;XmAb24306	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00324	Atezolizumab;Zanzalintinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00325	ATG037;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00326	Aumolertinib;Disitamab Vedotin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00327	Aumolertinib;Envafolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00328	Aumolertinib;Famitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00329	Aumolertinib;Gentuximab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00330	Aumolertinib;HS10241	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00331	Aumolertinib;Retlirafusp Alfa	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00332	Avadomide;Nivolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00332	Avadomide;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00333	Avadomide;Onatasertib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00334	Avadomide;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00335	Avadomide;Rituximab;Spebrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00336	Avadomide;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00337	Avelumab;Axitinib	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00337	Avelumab;Axitinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00337	Avelumab;Axitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC00337	Avelumab;Axitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00338	Avelumab;Batiraxcept	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00339	Avelumab;Bempegaldesleukin	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00340	Avelumab;Cetuximab	DrugComb	FD00002	Anal Cancer	Other Cancer	Phase 2
DC00340	Avelumab;Cetuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00340	Avelumab;Cetuximab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00341	Avelumab;Crizotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00342	Avelumab;KHK2455	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00343	Avelumab;Lenvatinib	DrugComb	FD00008	Central Nervous System Tumor	Other Cancer	Phase 1
DC00344	Avelumab;Lorlatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00345	Avelumab;Magrolimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00346	Avelumab;Mavelertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00347	Avelumab;Navtemadlin	DrugComb	FD00028	Merkel Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC00348	Avelumab;Pepinemab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00349	Avelumab;Peposertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00350	Avelumab;Rituximab;Utomilumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00351	Avelumab;Talazoparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00351	Avelumab;Talazoparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00351	Avelumab;Talazoparib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00352	Avelumab;Tomivosertib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00353	Avelumab;Trastuzumab;Utomilumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00354	Avelumab;Xevinapant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00355	Avutometinib;Defactinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00355	Avutometinib;Defactinib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00355	Avutometinib;Defactinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00356	Avutometinib;Everolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00356	Avutometinib;Everolimus	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00357	Avutometinib;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00358	Axatilimab;Durvalumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00358	Axatilimab;Durvalumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00359	Axatilimab;Nivolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00360	Axitinib;Erfonrilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00361	Axitinib;Ipilimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00362	Axitinib;Mavorixafor	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00363	Axitinib;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00364	Axitinib;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC00365	Axitinib;SEA-TGT;Sasanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00366	Axitinib;Sintilimab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00367	Axitinib;Tislelizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00368	Axitinib;Toripalimab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00368	Axitinib;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00368	Axitinib;Toripalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00369	AZD4547;Tislelizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00370	AZD4573;Acalabrutinib	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC00371	AZD5335;Saruparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00371	AZD5335;Saruparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00372	AZD8186;Abiraterone	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00373	AZD8186;Vistusertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00374	AZD8701;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00375	AZD9592;Osimertinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00375	AZD9592;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00376	Azenosertib;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00377	Azenosertib;Bevacizumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00378	Azenosertib;Cetuximab;Encorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00379	Azenosertib;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00380	Azintuxizumab Vedotin;Venetoclax	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00381	BA3071;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00382	Bafisontamab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00383	Balstilimab;Botensilimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00383	Balstilimab;Botensilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00383	Balstilimab;Botensilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00384	Balstilimab;CR6086	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00385	Balstilimab;Zalifrelimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00385	Balstilimab;Zalifrelimab	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC00386	Basiliximab;Pegaspargase	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00387	BAT1308;BAT6021	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00388	BAT1308;BAT6026	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00389	Batiraxcept;Cabozantinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00390	Batiraxcept;Cabozantinib;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00391	Batiraxcept;Durvalumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00392	Batoprotafib;Lorlatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00393	Batoprotafib;Opnurasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00394	Batoprotafib;Ribociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00395	Batoprotafib;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00396	Batoprotafib;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00397	Bavituximab;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00398	Bavituximab;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00398	Bavituximab;Pembrolizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00399	Bazedoxifene;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00400	BBP398;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00401	BBP398;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00402	BBP398;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00403	BCA101;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00404	BCL201;Idelalisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00405	BDB001;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00406	BDB018;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00407	BDC3042;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00408	Becotatug;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00409	Befotertinib;Icotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00410	Befotertinib;MCLA129	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00411	Belapectin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00412	Belinostat;Binimetinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00413	Belinostat;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00414	Belinostat;Talazoparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00414	Belinostat;Talazoparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00414	Belinostat;Talazoparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00415	Belrestotug;Dostarlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00416	Belrestotug;Inupadenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00417	Belrestotug;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00418	Belzutifan;Cabozantinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00419	Belzutifan;Lenvatinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00420	Belzutifan;Lenvatinib;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00420	Belzutifan;Lenvatinib;Pembrolizumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC00420	Belzutifan;Lenvatinib;Pembrolizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00420	Belzutifan;Lenvatinib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00420	Belzutifan;Lenvatinib;Pembrolizumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00421	Belzutifan;Palbociclib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00422	Bemcentinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00423	Bemcentinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00424	Bempegaldesleukin;Mivavotinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00425	Bempegaldesleukin;Nivolumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00425	Bempegaldesleukin;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00425	Bempegaldesleukin;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 3
DC00425	Bempegaldesleukin;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00425	Bempegaldesleukin;Nivolumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00426	Bempegaldesleukin;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2|Phase 3
DC00426	Bempegaldesleukin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00427	Benmelstobart;TQB2618	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00428	Benmelstobart;TQB3616	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00429	Bevacizumab;Bevacizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00430	Bevacizumab;Bortezomib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00430	Bevacizumab;Bortezomib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00430	Bevacizumab;Bortezomib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00431	Bevacizumab;Buparlisib	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00432	Bevacizumab;Camrelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00433	Bevacizumab;Capmatinib	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC00434	Bevacizumab;Carotuximab	DrugComb	FD00010	Choriocarcinoma	Other Cancer	Phase 2
DC00434	Bevacizumab;Carotuximab	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00434	Bevacizumab;Carotuximab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00435	Bevacizumab;Cediranib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00436	Bevacizumab;Cetuximab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00437	Bevacizumab;Cilengitide	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00438	Bevacizumab;Cobimetinib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00439	Bevacizumab;Crizotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00440	Bevacizumab;Dasatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00441	Bevacizumab;Denifanstat	DrugComb	FD00004	Astrocytoma	Other Cancer	Phase 2
DC00442	Bevacizumab;Divarasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00443	Bevacizumab;Durvalumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Early Phase 1
DC00443	Bevacizumab;Durvalumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00444	Bevacizumab;EMD1201081;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00445	Bevacizumab;Ensartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00446	Bevacizumab;Erlotinib	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00446	Bevacizumab;Erlotinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00446	Bevacizumab;Erlotinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00446	Bevacizumab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00447	Bevacizumab;Everolimus	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00447	Bevacizumab;Everolimus	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC00447	Bevacizumab;Everolimus	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC00448	Bevacizumab;Fuzuloparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00449	Bevacizumab;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00450	Bevacizumab;Icotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00451	Bevacizumab;Interferon alfa-2a	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00452	Bevacizumab;Lapatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00452	Bevacizumab;Lapatinib	DrugComb	FD00013	Ependymoma	Other Cancer	Phase 2
DC00453	Bevacizumab;Lazertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00454	Bevacizumab;Lenalidomide	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00455	Bevacizumab;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00456	Bevacizumab;Luveltamab Tazevibulin	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00457	Bevacizumab;ME344	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00458	Bevacizumab;MEDI3617	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00459	Bevacizumab;MINT1526A	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00460	Bevacizumab;Mirvetuximab Soravtansine	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00461	Bevacizumab;Nintedanib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00461	Bevacizumab;Nintedanib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC00461	Bevacizumab;Nintedanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00461	Bevacizumab;Nintedanib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00462	Bevacizumab;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00463	Bevacizumab;Nivolumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00463	Bevacizumab;Nivolumab	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00463	Bevacizumab;Nivolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00463	Bevacizumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00464	Bevacizumab;Nivolumab;Relatlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00465	Bevacizumab;Olaparib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 3
DC00465	Bevacizumab;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00465	Bevacizumab;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC00466	Bevacizumab;Onartuzumab	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00467	Bevacizumab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00468	Bevacizumab;Pamiparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00469	Bevacizumab;Panobinostat	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC00470	Bevacizumab;Pembrolizumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Approval
DC00471	Bevacizumab;Pucotenlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00472	Bevacizumab;Ridaforolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00473	Bevacizumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00474	Bevacizumab;Rucaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00475	Bevacizumab;Selinexor	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00476	Bevacizumab;Serplulimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00476	Bevacizumab;Serplulimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00477	Bevacizumab;Sintilimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2|Phase 3
DC00477	Bevacizumab;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00478	Bevacizumab;Sirolimus	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00479	Bevacizumab;Sorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00479	Bevacizumab;Sorafenib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00480	Bevacizumab;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00481	Bevacizumab;Temsirolimus	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC00481	Bevacizumab;Temsirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00481	Bevacizumab;Temsirolimus	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00482	Bevacizumab;Tisotumab Vedotin	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00483	Bevacizumab;Toripalimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00483	Bevacizumab;Toripalimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC00483	Bevacizumab;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00484	Bevacizumab;TRK950	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00484	Bevacizumab;TRK950	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00485	Bevacizumab;Tucidinostat	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC00485	Bevacizumab;Tucidinostat	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00486	Bevacizumab;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00487	Bevacizumab;Vorinostat	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00488	Bevacizumab;XB002	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00489	Bexarotene;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00490	Bexarotene;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00491	Bexarotene;Vorinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00492	Bexmarilimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00493	BGB15025;BGBA445	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00494	BGB15025;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00495	BGB30813;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00496	BGB3245;Mirdametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00497	BGB43395;Fulvestrant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00498	BGBA445;Sitravatinib;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00499	BGBA445;Tislelizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00499	BGBA445;Tislelizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC00499	BGBA445;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00499	BGBA445;Tislelizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00500	BGBB167;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00501	BI1387446;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00502	BI1701963;BI3011441	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00503	BI1701963;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00504	BI1701963;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00505	BI1703880;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00506	BI754111;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00506	BI754111;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Early Phase 1
DC00507	BI764532;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00507	BI764532;Ezabenlimab	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 1|Phase 2
DC00508	BI765049;Ezabenlimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00508	BI765049;Ezabenlimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00508	BI765049;Ezabenlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00508	BI765049;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00508	BI765049;Ezabenlimab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00509	BI765063;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00510	BI765179;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00511	BI770371;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00512	BI836826;Ibrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00513	BI836826;Idelalisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00514	BI836826;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00515	BI836880;Ezabenlimab	DrugComb	FD00002	Anal Cancer	Other Cancer	Phase 2
DC00515	BI836880;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00515	BI836880;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00516	BI891065;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00516	BI891065;Ezabenlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00517	Bicalutamide;Degarelix	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00518	Bicalutamide;Everolimus	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00519	Bicalutamide;Goserelin	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 3
DC00520	Bicalutamide;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00521	Bicalutamide;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00522	Bicalutamide;Panobinostat	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00523	Bicalutamide;Temsirolimus	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00524	Bicalutamide;Vandetanib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00525	Binimetinib;DCC3116	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00526	Binimetinib;Encorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC00526	Binimetinib;Encorafenib	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00526	Binimetinib;Encorafenib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00526	Binimetinib;Encorafenib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00527	Binimetinib;Encorafenib;Ipilimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00528	Binimetinib;Encorafenib;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00529	Binimetinib;Encorafenib;Sasanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00530	Binimetinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00531	Binimetinib;Exarafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00532	Binimetinib;Futibatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00533	Binimetinib;Ganitumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00534	Binimetinib;Imatinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00535	Binimetinib;Lorlatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00536	Binimetinib;Nilotinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00537	Binimetinib;Palbociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00538	Binimetinib;Panitumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00539	Binimetinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00540	Binimetinib;Pexidartinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1
DC00541	Binimetinib;PF07799933	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00542	Binimetinib;Ribociclib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00543	Binimetinib;Ripretinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC00544	Binimetinib;Tinlorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00545	Bintrafusp Alfa;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00546	Bintrafusp Alfa;Pimasertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00547	BIO106;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00548	Birinapant;Conatumumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00549	Birinapant;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00550	BLB01D1;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00551	BLB01D1;SI-B003	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00552	Blinatumomab;Lenalidomide	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00553	Blinatumomab;Pembrolizumab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC00553	Blinatumomab;Pembrolizumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00553	Blinatumomab;Pembrolizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00554	BLU701;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00555	BMS690514;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00556	BMS754807;Cetuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00556	BMS754807;Cetuximab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00557	BMS754807;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00558	BMS833923;Dasatinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00559	BMS908662;Cetuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00560	BMS986156;Ipilimumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00561	BMS986156;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00562	BMS986158;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00563	BMS986178;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00564	BMS986178;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00565	BMS986242;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00566	BMS986310;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00567	BMS986340;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00568	BMS986360;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00569	BMS986416;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00570	Bomedemstat;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00571	Bortezomib;Dacetuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00572	Bortezomib;Duvelisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00573	Bortezomib;Everolimus	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00574	Bortezomib;Ibrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00575	Bortezomib;KW2478	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00576	Bortezomib;Lenalidomide	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00576	Bortezomib;Lenalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00577	Bortezomib;Luminespib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00578	Bortezomib;Modakafusp Alfa	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00579	Bortezomib;Modakafusp Alfa;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00580	Bortezomib;Obatoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00581	Bortezomib;Ofatumumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00582	Bortezomib;Panobinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00582	Bortezomib;Panobinostat	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00583	Bortezomib;Perifosine	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00584	Bortezomib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00585	Bortezomib;Romidepsin	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00585	Bortezomib;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00585	Bortezomib;Romidepsin	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00586	Bortezomib;Ruxolitinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00587	Bortezomib;Selinexor	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00588	Bortezomib;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00589	Bortezomib;Temsirolimus	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00590	Bortezomib;Tipifarnib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00591	Bortezomib;Veligrotug	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00592	Bortezomib;Vorinostat	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00592	Bortezomib;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00592	Bortezomib;Vorinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00592	Bortezomib;Vorinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC00592	Bortezomib;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00593	Boserolimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00594	Brentuximab Vedotin;Lenalidomide	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00595	Brentuximab Vedotin;Nivolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00596	Brentuximab Vedotin;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00596	Brentuximab Vedotin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00596	Brentuximab Vedotin;Pembrolizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00596	Brentuximab Vedotin;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00597	Brentuximab Vedotin;SEA-TGT	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00598	Brentuximab Vedotin;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00599	Brigimadlin;Ezabenlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00600	Brivanib;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00601	BT5528;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00602	Budigalimab;Giloralimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00603	Budigalimab;Giloralimab;Revdofilimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00603	Budigalimab;Giloralimab;Revdofilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00604	Budigalimab;Livmoniplimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00605	Budigalimab;Revdofilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00606	Budigalimab;Rovalpituzumab Tesirine	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00607	Budigalimab;SC004	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00607	Budigalimab;SC004	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC00608	Budigalimab;SC006	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00609	Budigalimab;TTX030	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00610	Budigalimab;Venetoclax	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00611	Buparlisib;Capmatinib	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC00612	Buparlisib;Everolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00613	Buparlisib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00614	Buparlisib;Fulvestrant;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00615	Buparlisib;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00616	Buparlisib;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00617	Buparlisib;Letrozole;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00618	Buparlisib;Panitumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00619	Buparlisib;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00620	Buparlisib;Sonidegib	DrugComb	FD00005	Basal Cell Carcinoma	Other Cancer	Phase 2
DC00620	Buparlisib;Sonidegib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00621	Buparlisib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00622	Buparlisib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00623	Buparlisib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00624	BYON4228;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00625	Cabiralizumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00625	Cabiralizumab;Nivolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00625	Cabiralizumab;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00626	Cabiralizumab;Sotigalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00627	Cabozantinib;Durvalumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00628	Cabozantinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00628	Cabozantinib;Erlotinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00629	Cabozantinib;Ipilimumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00629	Cabozantinib;Ipilimumab;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00629	Cabozantinib;Ipilimumab;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00630	Cabozantinib;KO2806	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00631	Cabozantinib;Lanreotide	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC00632	Cabozantinib;Niraparib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC00633	Cabozantinib;Nivolumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00633	Cabozantinib;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC00633	Cabozantinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00633	Cabozantinib;Nivolumab	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC00634	Cabozantinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00635	Cabozantinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00636	Cadonilimab;Dresbuxelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00636	Cadonilimab;Dresbuxelimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00637	Cadonilimab;Lenvatinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00638	Camidanlumab Tesirine;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00639	Camizestrant;Saruparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00640	Camonsertib;RP6306	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00641	Camrelizumab;Dalpiciclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00642	Camrelizumab;Famitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00643	Camrelizumab;Fuzuloparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00644	Camrelizumab;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00645	Camrelizumab;Lenvatinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00646	Camrelizumab;Regorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 3
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00016	Gestational Trophoblastic Neoplasia	Other Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00647	Camrelizumab;Rivoceranib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00648	Canakinumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00649	Canakinumab;Spartalizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Early Phase 1
DC00649	Canakinumab;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00649	Canakinumab;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00650	Capivasertib;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00651	Capivasertib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00651	Capivasertib;Fulvestrant	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00652	Capivasertib;Olaparib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00653	Capivasertib;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00654	Capmatinib;Cetuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00654	Capmatinib;Cetuximab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00655	Capmatinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00656	Capmatinib;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00657	Capmatinib;Nazartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00658	Capmatinib;Neratinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00659	Capmatinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00660	Capmatinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00661	Capmatinib;Osimertinib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00662	Capmatinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00663	Capmatinib;Spartalizumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC00663	Capmatinib;Spartalizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00663	Capmatinib;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00663	Capmatinib;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00663	Capmatinib;Spartalizumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00664	Capmatinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00665	Carfilzomib;Daratumumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00666	Carfilzomib;Ibrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00667	Carfilzomib;Isatuximab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00668	Carfilzomib;Lenalidomide;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00669	Carfilzomib;Modakafusp Alfa	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00670	Carfilzomib;Panobinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00671	Carfilzomib;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00672	Carfilzomib;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00673	Carfilzomib;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00674	Carfilzomib;Vedolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00675	Carotuximab;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00676	Carotuximab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00677	Carotuximab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00678	Carotuximab;Pazopanib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC00679	Carotuximab;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00680	Casdozokitug;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00681	Casdozokitug;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00682	CB103;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00683	CBL0137;Ipilimumab;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Early Phase 1
DC00684	CDX1140;CDX301	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00684	CDX1140;CDX301	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC00685	CDX1140;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00686	CDX3379;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00687	Cediranib;Dasatinib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00688	Cediranib;Durvalumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00688	Cediranib;Durvalumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00688	Cediranib;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00688	Cediranib;Durvalumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00689	Cediranib;Durvalumab;Olaparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00689	Cediranib;Durvalumab;Olaparib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00689	Cediranib;Durvalumab;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00690	Cediranib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00691	Cediranib;Olaparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00691	Cediranib;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00691	Cediranib;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00691	Cediranib;Olaparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00692	Cediranib;RO4929097	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00693	Cemiplimab;Dupilumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00694	Cemiplimab;Fianlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00694	Cemiplimab;Fianlimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 3
DC00694	Cemiplimab;Fianlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00695	Cemiplimab;HST1011	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00696	Cemiplimab;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00697	Cemiplimab;Isatuximab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00698	Cemiplimab;OR2805	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00699	Cemiplimab;Pegenzileukin	DrugComb	FD00012	Cutaneous Squamous Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC00699	Cemiplimab;Pegenzileukin	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00700	Cemiplimab;REGN4659	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00701	Cemiplimab;REGN7075	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00702	Cemiplimab;S095018	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00703	Cemiplimab;S095024	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00704	Cemiplimab;S095029	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00705	Cemiplimab;Sarilumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00706	Cemiplimab;Tuvusertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00707	Cemiplimab;Ubamatamab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00708	Cemiplimab;Vidutolimod	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00709	Ceralasertib;Durvalumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00709	Ceralasertib;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00709	Ceralasertib;Durvalumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00709	Ceralasertib;Durvalumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00710	Ceralasertib;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00710	Ceralasertib;Olaparib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00710	Ceralasertib;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00710	Ceralasertib;Olaparib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC00711	Ceralasertib;Saruparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00712	Ceritinib;Everolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00713	Ceritinib;Luminespib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00714	Ceritinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00715	Ceritinib;Ribociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00716	Ceritinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00716	Ceritinib;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00717	Cetrelimab;Cetrelimab;Niraparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00718	Cetrelimab;Daratumumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2|Phase 3
DC00719	Cetrelimab;Erdafitinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00720	Cetrelimab;JNJ78278343	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00721	Cetrelimab;Niraparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00722	Cetuximab;Cixutumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00723	Cetuximab;Copanlisib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00724	Cetuximab;Divarasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00725	Cetuximab;Durvalumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00726	Cetuximab;Elgemtumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00727	Cetuximab;EMD1201081	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00728	Cetuximab;Encorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Approval
DC00729	Cetuximab;Encorafenib;Temuterkib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00729	Cetuximab;Encorafenib;Temuterkib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00729	Cetuximab;Encorafenib;Temuterkib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00730	Cetuximab;Erlotinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00730	Cetuximab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00730	Cetuximab;Erlotinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00731	Cetuximab;Evorpacept;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00732	Cetuximab;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00733	Cetuximab;Golvatinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00734	Cetuximab;IBI351	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00734	Cetuximab;IBI351	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00735	Cetuximab;Ibrutinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00736	Cetuximab;Imatinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Early Phase 1
DC00737	Cetuximab;JAB21822	DrugComb	FD00003	Appendix Cancer	Other Cancer	Phase 1|Phase 2
DC00737	Cetuximab;JAB21822	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00737	Cetuximab;JAB21822	DrugComb	FD00039	Small Intestine Cancer	Other Cancer	Phase 1|Phase 2
DC00738	Cetuximab;Lenalidomide	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00739	Cetuximab;Linsitinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00740	Cetuximab;LY3499446	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00741	Cetuximab;Magrolimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00742	Cetuximab;Monalizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 3
DC00743	Cetuximab;Motolimod	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00744	Cetuximab;Nanrilkefusp Alfa	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00745	Cetuximab;Neratinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00746	Cetuximab;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00747	Cetuximab;NKTR255	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00748	Cetuximab;Opnurasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00749	Cetuximab;Osimertinib;Tucatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00750	Cetuximab;Palbociclib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 3
DC00751	Cetuximab;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00751	Cetuximab;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00752	Cetuximab;PF07799933	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00753	Cetuximab;Prexasertib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00754	Cetuximab;Ridaforolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00755	Cetuximab;Selumetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00756	Cetuximab;Seribantumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00756	Cetuximab;Seribantumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00756	Cetuximab;Seribantumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00756	Cetuximab;Seribantumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00757	Cetuximab;Sirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00758	Cetuximab;Sorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00758	Cetuximab;Sorafenib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00759	Cetuximab;Temsirolimus	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00759	Cetuximab;Temsirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00760	Cetuximab;Tepotinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00761	Cetuximab;Tovorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00762	Cetuximab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00762	Cetuximab;Trastuzumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00763	Cetuximab;TTX080	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00764	Cetuximab;Urelumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00764	Cetuximab;Urelumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00765	Cetuximab;Vemurafenib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00766	CFI402411;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00767	CFT1946;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00768	Chiauranib;Tucidinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00769	CHS006;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00770	Cibisatamab;Elotuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00771	Cibisatamab;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00771	Cibisatamab;Nivolumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00772	Cibisatamab;Obinutuzumab;RO7122290	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00773	Ciforadenant;Mupadolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00774	Cifurtilimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00775	Cintirorgon;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00776	Cirmtuzumab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC00777	Citarinostat;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00778	Cixutumumab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00779	Cixutumumab;Everolimus;Octreotide	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00780	Cixutumumab;Temsirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00781	CLN619;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00782	CM24;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00783	CM24;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00784	CNF2024;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00785	Cobimetinib;Ipilimumab;Nivolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00786	Cobimetinib;LY3022855;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00787	Cobimetinib;Pictilisib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00788	Cobimetinib;Ravoxertinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00788	Cobimetinib;Ravoxertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00788	Cobimetinib;Ravoxertinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00789	Cobimetinib;Vemurafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC00789	Cobimetinib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00790	Cobimetinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00791	Cobolimab;Dostarlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00792	Cofetuzumab Pelidotin;Gedatolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00793	Coltuximab Ravtansine;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00794	COM701;COM902	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00795	COM701;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00796	Conatumumab;Ganitumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00797	Conatumumab;Panitumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00798	Copanlisib;Elimusertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00799	Copanlisib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00799	Copanlisib;Fulvestrant	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00800	Copanlisib;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00800	Copanlisib;Nivolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00800	Copanlisib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00800	Copanlisib;Nivolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00801	Copanlisib;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00802	Copanlisib;Pembrolizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00803	Copanlisib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC00804	Copanlisib;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00805	Copanlisib;Rucaparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00806	Copanlisib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00807	Copanlisib;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00808	Copanlisib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00809	Cosibelimab;Ublituximab;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00809	Cosibelimab;Ublituximab;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00810	CPGJ602;Cetuximab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00811	Crenigacestat;Samotolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00811	Crenigacestat;Samotolisib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00811	Crenigacestat;Samotolisib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00812	Crenigacestat;Taladegib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00812	Crenigacestat;Taladegib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00812	Crenigacestat;Taladegib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00813	Crizotinib;Dacomitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00814	Crizotinib;Dasatinib	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC00814	Crizotinib;Dasatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00815	Crizotinib;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00816	Crizotinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00817	Crizotinib;Ganetespib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00818	Crizotinib;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00819	Crizotinib;Lorlatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00820	Crizotinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00821	Crizotinib;Onalespib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00822	Crizotinib;Pazopanib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00823	Crizotinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00824	CS1002;Nofazinlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00825	CTX471;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00826	CUE101;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00827	Cusatuzumab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00828	Dabrafenib;Eprenetapopt	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00829	Dabrafenib;Itacitinib;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00830	Dabrafenib;Pembrolizumab;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00831	Dabrafenib;Spartalizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00832	Dabrafenib;Trametinib	DrugComb	FD00017	Glioma	Glioma	Approval
DC00832	Dabrafenib;Trametinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Approval
DC00832	Dabrafenib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC00832	Dabrafenib;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00832	Dabrafenib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00833	Dacomitinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00834	Dactolisib;Everolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00835	Dactolisib;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00836	Dalotuzumab;Dasatinib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00837	Dalotuzumab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00838	Dalotuzumab;Exemestane;Ridaforolimus	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00839	Dalotuzumab;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00840	Dalotuzumab;MK0752	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00841	Dalotuzumab;MK2206	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00842	Dalotuzumab;Ridaforolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00843	Dalpiciclib;Exemestane;Pyrotinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00844	Danvatirsen;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00844	Danvatirsen;Durvalumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00845	Daratumumab;Lenalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00846	Daratumumab;Lenalidomide;Talquetamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC00847	Daratumumab;Lenalidomide;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC00848	Daratumumab;Lenalidomide;Xentuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00849	Daratumumab;Maplirpacept	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00850	Daratumumab;Modakafusp Alfa	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00851	Daratumumab;Modakafusp Alfa;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00852	Daratumumab;Nivolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00852	Daratumumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00852	Daratumumab;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00853	Daratumumab;Pomalidomide	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC00853	Daratumumab;Pomalidomide	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC00853	Daratumumab;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC00853	Daratumumab;Pomalidomide	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC00853	Daratumumab;Pomalidomide	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Approval
DC00854	Daratumumab;Pomalidomide;Xentuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00855	Daratumumab;Tiragolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00855	Daratumumab;Tiragolumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00856	Daratumumab;XmAb24306	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00857	Dasatinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00858	Dasatinib;Everolimus	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC00859	Dasatinib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00860	Dasatinib;Nivolumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00860	Dasatinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00861	Dasatinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00862	Dasatinib;Tinodasertib	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC00863	Dasatinib;Vandetanib	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC00864	Datopotamab Deruxtecan;Durvalumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00865	Datopotamab Deruxtecan;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00866	Datopotamab Deruxtecan;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00867	Datopotamab Deruxtecan;Rilvegostomig	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00868	Datopotamab Deruxtecan;Saruparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00869	Datopotamab Deruxtecan;Volrustomig	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00870	Davoceticept;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00871	Dazostinag;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00872	DCC3116;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00873	DCC3116;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00874	Defactinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00875	Degarelix;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00876	Denenicokin;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00877	Denifanstat;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00878	Denileukin Diftitox;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC00879	Denileukin Diftitox;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00880	Denosumab;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC00881	Denosumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00882	Denosumab;Nivolumab;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00883	DF6002;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00884	DF9001;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00885	Dinaciclib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00886	Dinaciclib;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00886	Dinaciclib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00887	Dinaciclib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00888	Disitamab Vedotin;Envafolimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC00889	Disitamab Vedotin;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00890	Disitamab Vedotin;Penpulimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00891	Disitamab Vedotin;Pyrotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00892	Disitamab Vedotin;Tislelizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00892	Disitamab Vedotin;Tislelizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00893	Disitamab Vedotin;Toripalimab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 3
DC00894	Disitamab Vedotin;Tucatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00895	Divarasib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00896	Divarasib;GDC1971	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00897	Divarasib;Inavolisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00898	Divarasib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00899	DKY709;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00900	Domvanalimab;Etrumadenant;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00901	Domvanalimab;Sacituzumab Govitecan;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00902	Domvanalimab;Sotigalimab;Zimberelimab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC00903	Domvanalimab;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00904	Dostarlimab;Encelimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00905	Dostarlimab;Niraparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00905	Dostarlimab;Niraparib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00905	Dostarlimab;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00905	Dostarlimab;Niraparib	DrugComb	FD00036	Penile Cancer	Other Cancer	Phase 2
DC00906	Dovitinib;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00907	Dovitinib;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00907	Dovitinib;Fulvestrant	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2|Phase 3
DC00908	Dresbuxelimab;Ivonescimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00908	Dresbuxelimab;Ivonescimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00909	Drozitumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00910	DS1103a;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00911	DS1205c;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00912	DS1205c;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00913	DS8273a;Nivolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00913	DS8273a;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00914	Dubermatinib;Ibrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00914	Dubermatinib;Ibrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00915	Dulanermin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00916	Duligotuzumab;Etrumadenant	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC00917	Durvalumab;Enfortumab Vedotin	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 3
DC00918	Durvalumab;Enfortumab Vedotin;Tremelimumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 3
DC00919	Durvalumab;Ensartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00920	Durvalumab;Epacadostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00921	Durvalumab;Galunisertib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00922	Durvalumab;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00923	Durvalumab;Ibrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00923	Durvalumab;Ibrutinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00923	Durvalumab;Ibrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00924	Durvalumab;Imaradenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00925	Durvalumab;Imaradenant;Oleclumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00926	Durvalumab;Ipilimumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00927	Durvalumab;Lenalidomide	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC00928	Durvalumab;Lenalidomide;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00929	Durvalumab;LY2510924	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00930	Durvalumab;LY3022855	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00931	Durvalumab;Mecbotamab Vedotin	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00932	Durvalumab;Monalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00933	Durvalumab;Ocifisertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00934	Durvalumab;Olaparib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00934	Durvalumab;Olaparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00934	Durvalumab;Olaparib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC00934	Durvalumab;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00934	Durvalumab;Olaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00935	Durvalumab;Oleclumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00935	Durvalumab;Oleclumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00936	Durvalumab;Oportuzumab Monatox	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00937	Durvalumab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC00938	Durvalumab;Ozuriftamab Vedotin	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00939	Durvalumab;Pertuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00940	Durvalumab;Pexidartinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00940	Durvalumab;Pexidartinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00941	Durvalumab;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00942	Durvalumab;Ramucirumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00942	Durvalumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00942	Durvalumab;Ramucirumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00943	Durvalumab;Savolitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00943	Durvalumab;Savolitinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00944	Durvalumab;Selumetinib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00944	Durvalumab;Selumetinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00944	Durvalumab;Selumetinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00945	Durvalumab;Selumetinib;Tremelimumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00946	Durvalumab;Tebentafusp	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00947	Durvalumab;Telratolimod	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00948	Durvalumab;Tivozanib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC00949	Durvalumab;Trametinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00950	Durvalumab;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00950	Durvalumab;Trastuzumab Deruxtecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00015	Germ Cell Tumor	Other Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Approval
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00029	Mesothelioma	Other Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00037	Pleural Mesothelioma	Other Cancer	Phase 2
DC00951	Durvalumab;Tremelimumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC00952	Durvalumab;Vactosertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00953	Durvalumab;Vistusertib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00953	Durvalumab;Vistusertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00954	Duvelisib;Enlonstobart	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC00955	Duvelisib;Nivolumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00955	Duvelisib;Nivolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00955	Duvelisib;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00956	Duvelisib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC00957	Duvelisib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC00958	Duvelisib;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00959	Duvelisib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00959	Duvelisib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC00960	Duvortuxizumab;Ibrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00960	Duvortuxizumab;Ibrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00961	DV281;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00962	E7386;Lenvatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00963	EBC129;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00964	Efatutazone;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00965	Efineptakin Alfa;Nivolumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC00965	Efineptakin Alfa;Nivolumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00966	Efineptakin Alfa;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00967	Eftozanermin Alfa;Venetoclax	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC00967	Eftozanermin Alfa;Venetoclax	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00968	Eganelisib;Nivolumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00968	Eganelisib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00969	Elacestrant;Onapristone	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC00970	Elgemtumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC00970	Elgemtumab;Trastuzumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC00971	Elotuzumab;Nivolumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00972	Elotuzumab;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00973	Elotuzumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC00974	Elotuzumab;Urelumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC00975	Eluvixtamab;Pembrolizumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC00976	ELVN002;Trastuzumab Emtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00977	Emactuzumab;Selicrelumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00978	Emavusertib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00978	Emavusertib;Venetoclax	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC00979	Emibetuzumab;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00980	Emibetuzumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC00981	Enasidenib;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC00982	Enasidenib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC00983	Encorafenib;Ipilimumab;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00984	Encorafenib;Ribociclib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC00985	Endostatin;Envafolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00986	Endostatin;Toripalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00987	Enfortumab Vedotin;Evorpacept	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC00988	Enfortumab Vedotin;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Approval
DC00989	Enitociclib;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC00990	Enoblituzumab;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00991	Enoblituzumab;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC00991	Enoblituzumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00991	Enoblituzumab;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC00992	Enoblituzumab;Retifanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC00993	Enoblituzumab;Tebotelimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2|Phase 3
DC00994	Enristomig;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00995	Entinostat;Enzalutamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC00996	Entinostat;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC00997	Entinostat;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC00998	Entinostat;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC00999	Entinostat;Isotretinoin	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01000	Entinostat;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01001	Entinostat;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01001	Entinostat;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01001	Entinostat;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01001	Entinostat;Pembrolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01002	Entospletinib;Idelalisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01002	Entospletinib;Idelalisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01003	Entospletinib;Obinutuzumab;Tirabrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01004	Entospletinib;Tirabrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01005	Envafolimab;Lenvatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01006	Envafolimab;Sunitinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01007	Envafolimab;Tucidinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01008	Enzalutamide;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01009	Enzalutamide;Galunisertib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01010	Enzalutamide;GSK2636771	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01011	Enzalutamide;Imaradenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01012	Enzalutamide;Niclosamide	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01013	Enzalutamide;Niraparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01014	Enzalutamide;NUV422	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC01015	Enzalutamide;Ribociclib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC01016	Enzalutamide;Samotolisib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01017	Enzalutamide;Talazoparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Approval
DC01018	Enzalutamide;Tivozanib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01019	Enzalutamide;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01020	Enzalutamide;ZEN003694	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01021	Enzastaurin;Erlotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01022	Enzastaurin;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01023	Enzastaurin;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01024	Epacadostat;INCB059872;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01024	Epacadostat;INCB059872;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01025	Epacadostat;Itacitinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01026	Epacadostat;Nivolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01026	Epacadostat;Nivolumab	DrugComb	FD00017	Glioma	Glioma	Phase 1|Phase 2
DC01026	Epacadostat;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01026	Epacadostat;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01026	Epacadostat;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01026	Epacadostat;Nivolumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01027	Epacadostat;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 3
DC01027	Epacadostat;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 3
DC01027	Epacadostat;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC01027	Epacadostat;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01028	Epacadostat;Pembrolizumab;Ragifilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01029	Epacadostat;Sirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01030	Epacmarstobart;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01031	Epoetin Alfa;Panobinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01032	Eprenetapopt;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01033	ERAS007;ERAS601	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01034	ERAS007;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01035	ERAS007;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01036	ERAS601;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01037	Erfonrilimab;Lenvatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC01038	Erfonrilimab;Ningetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01039	Erlotinib;Everolimus	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01039	Erlotinib;Everolimus	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01039	Erlotinib;Everolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01040	Erlotinib;Figitumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01041	Erlotinib;Foretinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01042	Erlotinib;Fulvestrant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01043	Erlotinib;Gilteritinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01044	Erlotinib;Glesatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01045	Erlotinib;Goserelin;Letrozole;Linsitinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01046	Erlotinib;Ipilimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01047	Erlotinib;IRX4204	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01048	Erlotinib;Itacitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01049	Erlotinib;Linifanib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01050	Erlotinib;Linsitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01051	Erlotinib;Luminespib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01052	Erlotinib;LY2584702	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01053	Erlotinib;LY3499446	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01054	Erlotinib;MK2206	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01054	Erlotinib;MK2206	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01055	Erlotinib;Momelotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01056	Erlotinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01057	Erlotinib;Onalespib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01058	Erlotinib;Onartuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01059	Erlotinib;Onatasertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01060	Erlotinib;Pacritinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01061	Erlotinib;Panobinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01062	Erlotinib;Patritumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01063	Erlotinib;Pazopanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01064	Erlotinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01065	Erlotinib;Pertuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01066	Erlotinib;Pictilisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01067	Erlotinib;Pilaralisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01068	Erlotinib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC01069	Erlotinib;Rilotumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01070	Erlotinib;Rivoceranib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01071	Erlotinib;RO4929097	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01072	Erlotinib;Romidepsin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01073	Erlotinib;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01074	Erlotinib;Seribantumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01075	Erlotinib;Sirolimus	DrugComb	FD00015	Germ Cell Tumor	Other Cancer	Phase 2
DC01076	Erlotinib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC01076	Erlotinib;Sorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01077	Erlotinib;Telisotuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01078	Erlotinib;Teprotumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01079	Erlotinib;Tivantinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01080	Erlotinib;Tivozanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01081	Erlotinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01081	Erlotinib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01082	Erlotinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01083	Erlotinib;Volociximab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01084	Erlotinib;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01085	Erlotinib;Voxtalisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01086	ES102;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01087	ES102;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01088	ESK981;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01089	ETC1922159;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01090	Etevritamab;Zeluvalimab	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC01091	Etigilimab;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01092	Etrumadenant;Sacituzumab Govitecan;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01093	Etrumadenant;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01093	Etrumadenant;Zimberelimab	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01094	Everolimus;Exemestane	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01095	Everolimus;Exemestane;Xentuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01096	Everolimus;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01097	Everolimus;Ganitumab;Panitumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01098	Everolimus;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01099	Everolimus;Giredestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01100	Everolimus;Idelalisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01100	Everolimus;Idelalisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01101	Everolimus;Imatinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01101	Everolimus;Imatinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01101	Everolimus;Imatinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01101	Everolimus;Imatinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01102	Everolimus;Itacitinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01103	Everolimus;Lenalidomide	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01104	Everolimus;Lenvatinib	DrugComb	FD00008	Central Nervous System Tumor	Other Cancer	Phase 1|Phase 2
DC01104	Everolimus;Lenvatinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC01104	Everolimus;Lenvatinib	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC01105	Everolimus;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01105	Everolimus;Letrozole	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01106	Everolimus;LY2584702	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01107	Everolimus;Neratinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01108	Everolimus;Niraparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01108	Everolimus;Niraparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01109	Everolimus;Octreotide	DrugComb	FD00027	Meningioma	Other Cancer	Phase 2
DC01110	Everolimus;Panobinostat	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC01110	Everolimus;Panobinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01111	Everolimus;Pasireotide	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01111	Everolimus;Pasireotide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01111	Everolimus;Pasireotide	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 1
DC01112	Everolimus;Pazopanib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC01112	Everolimus;Pazopanib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01113	Everolimus;Retaspimycin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01114	Everolimus;Ribociclib	DrugComb	FD00017	Glioma	Glioma	Early Phase 1
DC01114	Everolimus;Ribociclib	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC01114	Everolimus;Ribociclib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01115	Everolimus;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01116	Everolimus;Sonidegib	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC01117	Everolimus;Sorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01117	Everolimus;Sorafenib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01117	Everolimus;Sorafenib	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 1
DC01117	Everolimus;Sorafenib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01118	Everolimus;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01119	Everolimus;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01120	Everolimus;Telaglenastat	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01121	Everolimus;Teprotumumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01122	Everolimus;Tivozanib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01123	Everolimus;Trametinib	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC01124	Everolimus;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01125	Everolimus;Vemurafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01126	Everolimus;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01127	Everolimus;Vorsetzumab Mafodotin	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01128	Evolocumab;Ipilimumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01129	Evorpacept;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01130	Evorpacept;Zanidatamab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01131	Exemestane;Fulvestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01132	Exemestane;Fulvestrant;Tasurgratinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01133	Exemestane;PF04691502	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01134	Exemestane;Ridaforolimus	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01135	Exemestane;Ruxolitinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01136	Exemestane;Sapanisertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01137	Exemestane;Seribantumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01138	Exemestane;Tucidinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01139	Exlinkibart;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01140	Fadraciclib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01140	Fadraciclib;Venetoclax	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01141	Famitinib;Retlirafusp Alfa	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01142	Favezelimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01143	FAZ053;Spartalizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01144	Fenretinide;Lonafarnib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01145	Ficlatuzumab;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01146	Figitumumab;Sunitinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01147	FL101;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01148	Foretinib;Lapatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01149	Foslinanib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01150	Fostamatinib;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01151	Fruquintinib;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01152	Fruquintinib;Geptanolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01153	Fruquintinib;Sintilimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01153	Fruquintinib;Sintilimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01154	Fruquintinib;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01155	Fruquintinib;Toripalimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01156	Fulvestrant;Ganetespib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01157	Fulvestrant;Gefitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01158	Fulvestrant;Goserelin;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01159	Fulvestrant;Inavolisib;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2|Phase 3
DC01160	Fulvestrant;Ipatasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01161	Fulvestrant;Ipatasertib;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01162	Fulvestrant;Ixazomib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01163	Fulvestrant;Lerociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01164	Fulvestrant;Luvixasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01165	Fulvestrant;Mirdametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01166	Fulvestrant;Neratinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01167	Fulvestrant;Neratinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01168	Fulvestrant;NUV422	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01169	Fulvestrant;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01170	Fulvestrant;Palbociclib;Zanidatamab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01171	Fulvestrant;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01172	Fulvestrant;Pertuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01173	Fulvestrant;PF07224826	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01174	Fulvestrant;PF07248144	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01175	Fulvestrant;Pictilisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01176	Fulvestrant;Regorafenib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01177	Fulvestrant;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01178	Fulvestrant;Ribociclib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01179	Fulvestrant;RLY2608	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01180	Fulvestrant;Samotolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01180	Fulvestrant;Samotolisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01180	Fulvestrant;Samotolisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01181	Fulvestrant;Sapanisertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01182	Fulvestrant;Tasurgratinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01183	Fulvestrant;Tipifarnib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01184	Fulvestrant;TQ-B3525	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01185	Fulvestrant;TQB3616	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01186	Fulvestrant;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01187	Fulvestrant;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01188	Fulvestrant;Tucidinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01189	Fulvestrant;Vandetanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01189	Fulvestrant;Vandetanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01190	Fulvestrant;Veligrotug	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01191	Fulvestrant;Venetoclax	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01192	Fulvestrant;Vevorisertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01193	Fulvestrant;Vistusertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01193	Fulvestrant;Vistusertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01194	Fulvestrant;XL102	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01195	Fulvestrant;XZP3287	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01196	Futibatinib;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01197	Fuzuloparib;Retlirafusp Alfa	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01198	Fuzuloparib;Rivoceranib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01198	Fuzuloparib;Rivoceranib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01198	Fuzuloparib;Rivoceranib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01199	Galunisertib;Nivolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01199	Galunisertib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01200	Galunisertib;Ramucirumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01201	Galunisertib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01202	Gancotamab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2|Phase 3
DC01203	Ganetespib;Sirolimus	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC01204	Ganitumab;Panitumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01204	Ganitumab;Panitumumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01205	Ganitumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01206	Garivulimab;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01207	Garsorasib;Ifebemtinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01208	GDC1971;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01209	Gedatolisib;Mirdametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01210	Gedatolisib;Palbociclib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01210	Gedatolisib;Palbociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01210	Gedatolisib;Palbociclib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01211	Gedatolisib;Talazoparib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01212	Gefitinib;MK2206	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01213	Gefitinib;Nazartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01214	Gefitinib;Nimotuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01215	Gefitinib;Ningetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01216	Gefitinib;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01217	Gefitinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01218	Gefitinib;Osimertinib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01219	Gefitinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01220	Gefitinib;Rivoceranib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01221	Gefitinib;Savolitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01222	Gefitinib;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01223	Gefitinib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01224	Gefitinib;Tepotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01225	Gefitinib;Tremelimumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01226	Gefitinib;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01227	Gemtuzumab Ozogamicin;Zosuquidar	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01228	GFH018;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01229	GI101;Lenvatinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01230	GI101;Pembrolizumab	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC01231	Giloralimab;Revdofilimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01231	Giloralimab;Revdofilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01232	Gilteritinib;Lanraplenib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01233	Gilteritinib;Midostaurin	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01233	Gilteritinib;Midostaurin	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC01234	Gilteritinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01235	Giredestrant;Inavolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01236	Giredestrant;Ipatasertib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01237	Giredestrant;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01238	Giredestrant;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01239	Giredestrant;Samuraciclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01240	Glesatinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01241	GLS012;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01242	Golcadomide;Ianalumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01243	Golcadomide;Obinutuzumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01243	Golcadomide;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01244	Golidocitinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01245	Golidocitinib;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01246	Goserelin;Letrozole;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01247	Goserelin;Letrozole;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01248	Goserelin;Palbociclib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01249	Goserelin;Ribociclib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01250	Goserelin;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01251	Gotistobart;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01252	GS1811;Zimberelimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01253	GSK2256098;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01254	GSK2636771;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01255	GSK3145095;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01256	GSK3174998;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01257	GT103;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01258	Gumarontinib;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01259	H3B6545;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01260	HFB200301;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01261	HFB200603;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01262	HLX04;Serplulimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2|Phase 3
DC01262	HLX04;Serplulimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01263	HLX208;Serplulimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01264	HLX26;Serplulimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01264	HLX26;Serplulimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01265	HMBD002;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01266	HS10241;Rivoceranib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01267	Ianalumab;Lenalidomide	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01268	Iberdomide;Lenalidomide;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01269	Iberdomide;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01270	IBI110;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01271	IBI318;Lenvatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01272	IBI351;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01273	Ibritumomab Tiuxetan;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01274	Ibrutinib;Ibrutinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01274	Ibrutinib;Ibrutinib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01275	Ibrutinib;Itacitinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01276	Ibrutinib;Lenalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01277	Ibrutinib;Lenalidomide;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01278	Ibrutinib;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01278	Ibrutinib;Nivolumab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC01278	Ibrutinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01279	Ibrutinib;Obinutuzumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01279	Ibrutinib;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01280	Ibrutinib;Obinutuzumab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01280	Ibrutinib;Obinutuzumab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01281	Ibrutinib;Pacritinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01281	Ibrutinib;Pacritinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01282	Ibrutinib;Palbociclib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01283	Ibrutinib;Pembrolizumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01284	Ibrutinib;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Approval
DC01284	Ibrutinib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC01285	Ibrutinib;Rituximab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01286	Ibrutinib;Safimaltib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01287	Ibrutinib;Temuterkib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01287	Ibrutinib;Temuterkib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01288	Ibrutinib;Ublituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01288	Ibrutinib;Ublituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01289	Ibrutinib;Ublituximab;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01289	Ibrutinib;Ublituximab;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01290	Ibrutinib;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01290	Ibrutinib;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01291	Ibrutinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01291	Ibrutinib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01292	Ibrutinib;Vistusertib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01293	Idasanutlin;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01294	Idasanutlin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01295	Idasanutlin;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01295	Idasanutlin;Venetoclax	DrugComb	FD00031	Neuroblastoma	Other Cancer	Phase 1|Phase 2
DC01296	Idelalisib;Lenalidomide;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01296	Idelalisib;Lenalidomide;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01297	Idelalisib;Obinutuzumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01298	Idelalisib;Obinutuzumab;Tirabrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01299	Idelalisib;Ofatumumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01299	Idelalisib;Ofatumumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01300	Idelalisib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01301	Idelalisib;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Approval
DC01301	Idelalisib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01302	Idelalisib;Tirabrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01303	Ieramilimab;Spartalizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01303	Ieramilimab;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01303	Ieramilimab;Spartalizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01304	ILB2109;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01305	Imaradenant;Oleclumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01306	Imatinib;Rivoceranib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01307	Imatinib;Selinexor	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC01308	Imatinib;Tipifarnib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01309	Imatinib;Vactosertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01310	Imiquimod;Zalifrelimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01311	INCAGN01949;Ipilimumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01312	INCAGN01949;Ipilimumab;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01313	INCAGN01949;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01314	INCB081776;Retifanlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01315	INCB106385;Retifanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01316	INCB7839;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01317	Indoximod;Ipilimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01318	Indoximod;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01319	Indoximod;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01320	Inebilizumab;Rituximab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01321	Inetetamab;Pyrotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01322	Inezetamab;Zeluvalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01323	Infliximab;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01324	Inobrodib;Olaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01325	Inotuzumab Ozogamicin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01326	Ipatasertib;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01327	Ipatasertib;Pertuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01328	Ipilimumab;Izuralimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01329	Ipilimumab;Lenalidomide	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01330	Ipilimumab;Linrodostat;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01331	Ipilimumab;Nintedanib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00008	Central Nervous System Tumor	Other Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00029	Mesothelioma	Other Cancer	Approval
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC01332	Ipilimumab;Nivolumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 3
DC01333	Ipilimumab;Nivolumab;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01334	Ipilimumab;Nivolumab;Pexmetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01335	Ipilimumab;Nivolumab;Ragifilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01336	Ipilimumab;Nivolumab;Renvistobart	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01337	Ipilimumab;Nivolumab;Rovalpituzumab Tesirine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01338	Ipilimumab;Nivolumab;Tazemetostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01339	Ipilimumab;Nivolumab;Tilsotolimod	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01340	Ipilimumab;Nivolumab;Tocilizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01341	Ipilimumab;Nivolumab;Zanzalintinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01341	Ipilimumab;Nivolumab;Zanzalintinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01342	Ipilimumab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01343	Ipilimumab;Pacmilimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01344	Ipilimumab;Panobinostat	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01345	Ipilimumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01345	Ipilimumab;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01346	Ipilimumab;Pepinemab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01347	Ipilimumab;Ragifilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01348	Ipilimumab;Relatlimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01349	Ipilimumab;Sintilimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01349	Ipilimumab;Sintilimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01349	Ipilimumab;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01349	Ipilimumab;Sintilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01349	Ipilimumab;Sintilimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01350	Ipilimumab;Tilsotolimod	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01351	Ipilimumab;Tivumecirnon	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01352	Ipilimumab;Tretinoin	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01353	Ipilimumab;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01354	Ipilimumab;Vopratelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01355	Isatuximab;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC01356	Isatuximab;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01357	Isotretinoin;Vorinostat	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC01357	Isotretinoin;Vorinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01357	Isotretinoin;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01358	Istiratumab;MM151	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01358	Istiratumab;MM151	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01358	Istiratumab;MM151	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01359	Itacitinib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01360	Itacitinib;Parsaclisib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01361	Itacitinib;Pembrolizumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01362	Itacitinib;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01363	Ixazomib;Lenalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01364	Ixazomib;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01365	Ixazomib;Selinexor	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1
DC01366	Izalontamab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC01367	Izalontamab;SI-B003	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01367	Izalontamab;SI-B003	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01368	Izuralimab;Pavunalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01369	JAB21822;JAB3312	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01369	JAB21822;JAB3312	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01369	JAB21822;JAB3312	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC01370	JAB3068;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01371	JNJ64264681;Safimaltib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01372	KBA1412;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01373	KD6001;Toripalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01374	KHK2455;Mogamulizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01375	KTN3379;Vemurafenib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01376	KVA12123;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01377	Lacnotuzumab;Spartalizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01377	Lacnotuzumab;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01377	Lacnotuzumab;Spartalizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01377	Lacnotuzumab;Spartalizumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC01378	Ladarixin;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01379	Ladiratuzumab Vedotin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01380	Lapatinib;Letrozole	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01381	Lapatinib;MK2206;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01382	Lapatinib;Pazopanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01382	Lapatinib;Pazopanib	DrugComb	FD00017	Glioma	Glioma	Phase 2
DC01382	Lapatinib;Pazopanib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01383	Lapatinib;Sirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01384	Lapatinib;Trametinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01385	Lapatinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01385	Lapatinib;Trastuzumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01386	Lapatinib;Vorinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01387	Lazertinib;Tepotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01388	LBL007;Tislelizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01388	LBL007;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01389	LCL161;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01390	Lemzoparlimab;Pembrolizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01390	Lemzoparlimab;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01391	Lemzoparlimab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01391	Lemzoparlimab;Rituximab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01392	Lemzoparlimab;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01393	Lenalidomide;lintuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01394	Lenalidomide;Loncastuximab Tesirine	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01395	Lenalidomide;Modakafusp Alfa	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01396	Lenalidomide;Obinutuzumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01396	Lenalidomide;Obinutuzumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01397	Lenalidomide;Obinutuzumab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01398	Lenalidomide;Ofatumumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01398	Lenalidomide;Ofatumumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01399	Lenalidomide;Panobinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01400	Lenalidomide;Rituximab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 2
DC01400	Lenalidomide;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01400	Lenalidomide;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC01401	Lenalidomide;Rituximab;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01402	Lenalidomide;Rituximab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01403	Lenalidomide;Romidepsin	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01404	Lenalidomide;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01404	Lenalidomide;Sorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01405	Lenalidomide;Spebrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01405	Lenalidomide;Spebrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01406	Lenalidomide;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC01407	Lenalidomide;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC01408	Lenalidomide;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC01409	Lenalidomide;Temsirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01410	Lenalidomide;Tocilizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01411	Lenalidomide;Tocilizumab;Vanucizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01412	Lenalidomide;Tretinoin	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01413	Lenalidomide;Ublituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01414	Lenalidomide;Vanucizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01415	Lenalidomide;Vedolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01416	Lenalidomide;Vorinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01417	Lenalidomide;Xentuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01418	Lenalidomide;Zanubrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 3
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Approval
DC01419	Lenvatinib;Pembrolizumab	DrugComb	FD00043	Vulvar Cancer	Other Cancer	Phase 2
DC01420	Lenvatinib;Pucotenlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01421	Lenvatinib;Sintilimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01422	Lenvatinib;Tislelizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01422	Lenvatinib;Tislelizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01422	Lenvatinib;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01423	Lenvatinib;Toripalimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC01424	Lerociclib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01425	Letaplimab;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01426	Letrozole;Nintedanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01427	Letrozole;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01427	Letrozole;Palbociclib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01428	Letrozole;Palbociclib;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01429	Letrozole;Palbociclib;Venetoclax	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01430	Letrozole;Patritumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01431	Letrozole;Pictilisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01432	Letrozole;Pilaralisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01433	Letrozole;Ribociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01434	Letrozole;Sontuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01435	Letrozole;Teprotumumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01436	Letrozole;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01437	Letrozole;Vatalanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01438	Letrozole;XZP3287	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01439	LHC165;Spartalizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01440	Lifirafenib;Mirdametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01441	Linrodostat;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01441	Linrodostat;Nivolumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01441	Linrodostat;Nivolumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01442	Lirilumab;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01443	Lisaftoclax;Palbociclib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01444	Lodapolimab;Merestinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01444	Lodapolimab;Merestinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01444	Lodapolimab;Merestinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01445	Lodapolimab;Prexasertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01446	Lodapolimab;Ramucirumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01446	Lodapolimab;Ramucirumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01446	Lodapolimab;Ramucirumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01447	Loncastuximab Tesirine;Polatuzumab Vedotin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01448	Loncastuximab Tesirine;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01449	Loncastuximab Tesirine;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01450	Lorigerlimab;Vobramitamab Duocarmazine	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01451	Lorlatinib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01452	Lucitanib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01453	Luminespib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01453	Luminespib;Trastuzumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01454	LY2510924;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01455	LY2874455;Merestinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01456	LY3022855;Tremelimumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01457	LY3200882;Lodapolimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01458	LY3295668;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01459	LY3321367;Lodapolimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01459	LY3321367;Lodapolimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01459	LY3321367;Lodapolimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01459	LY3321367;Lodapolimab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01460	LY3381916;Lodapolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01461	LY3475070;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01462	LY3537982;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01463	Magrolimab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01464	Mapatumumab;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01465	Marizomib;Panobinostat	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC01466	Marizomib;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01467	Mavelertinib;Palbociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01468	Mavorixafor;Toripalimab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01469	MAX40279;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01470	MCLA129;Osimertinib	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC01470	MCLA129;Osimertinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01470	MCLA129;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01470	MCLA129;Osimertinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01471	Merestinib;Ramucirumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01471	Merestinib;Ramucirumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01472	Mifcemalimab;Toripalimab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01472	Mifcemalimab;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01473	MIK665;VOB560	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01473	MIK665;VOB560	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01474	Mirdametinib;Palbociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01475	Mirvetuximab Soravtansine;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01476	Mivavotinib;Nivolumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01476	Mivavotinib;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01476	Mivavotinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01477	Mivavotinib;Serabelisib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01478	Mivavotinib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01479	MK0482;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01480	MK0752;Ridaforolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01481	MK1248;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01482	MK1484;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01483	MK1966;SD101	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01484	MK2206;Ridaforolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01485	MK2206;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01485	MK2206;Selumetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01486	MK4166;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01487	MK4621;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01488	MK4830;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01489	MK7162;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01490	MK8353;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01491	MK8353;Selumetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01492	MM151;Seribantumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01492	MM151;Seribantumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01492	MM151;Seribantumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01493	MM151;Talquetamab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01493	MM151;Talquetamab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01493	MM151;Talquetamab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01494	MM151;Trametinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01494	MM151;Trametinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01494	MM151;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01495	Mocetinostat;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01496	Modakafusp Alfa;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01497	Modakafusp Alfa;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01498	Mogamulizumab;Nivolumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC01498	Mogamulizumab;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01498	Mogamulizumab;Nivolumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01498	Mogamulizumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01498	Mogamulizumab;Nivolumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01499	Mogamulizumab;Utomilumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01500	Momelotinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01501	Motesanib;Panitumumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01502	Motolimod;Nivolumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01503	MP0250;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01504	MRX2843;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01505	MT8421;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01506	MTL501;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01507	Mupadolimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01508	Nanrilkefusp Alfa;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01509	Napabucasin;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01510	Naporafenib;Nazartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01511	Naporafenib;Ribociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01511	Naporafenib;Ribociclib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01512	Naporafenib;Rineterkib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01512	Naporafenib;Rineterkib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01513	Naporafenib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01513	Naporafenib;Trametinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01514	Naratuximab Emtansine;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01515	Navarixin;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01515	Navarixin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01515	Navarixin;Pembrolizumab	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01516	Navitoclax;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01517	Navitoclax;Rituximab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC01517	Navitoclax;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01518	Navitoclax;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01518	Navitoclax;Ruxolitinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01519	Navtemadlin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01520	Navtemadlin;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01521	Navtemadlin;TL895	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01521	Navtemadlin;TL895	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01521	Navtemadlin;TL895	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01522	Navtemadlin;Trametinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01523	Nazartinib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01524	Nazartinib;Ribociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01525	Nazartinib;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01526	Nazartinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01527	NC318;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01528	NC410;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01529	NDI101150;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01530	Necitumumab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01531	Necitumumab;Osimertinib;Trastuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01532	Necitumumab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01533	Necitumumab;Samotolisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01534	Nemtabrutinib;Zilovertamab Vedotin	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01534	Nemtabrutinib;Zilovertamab Vedotin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01535	Nemvaleukin Alfa;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01535	Nemvaleukin Alfa;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01536	NEO201;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01537	Neratinib;Palbociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01538	Neratinib;Temsirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01539	Neratinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01540	Neratinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01541	Neratinib;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01542	NG641;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01543	NGM438;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01544	NGM707;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01545	NGM831;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01546	Nidanilimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01547	Nilotinib;Ruxolitinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01548	Nimotuzumab;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01549	Nintedanib;Nivolumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01550	Nintedanib;Volasertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01551	Niraparib;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01552	Niraparib;Panitumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01553	Niraparib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01553	Niraparib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01553	Niraparib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01554	Niraparib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01555	Niraparib;Trastuzumab Duocarmazine	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01556	Nirogacestat;Teclistamab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01557	Nirogacestat;Xentuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01558	Nisevokitug;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01559	Nivolumab;ONO4578	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01560	Nivolumab;Osemitamab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC01560	Nivolumab;Osemitamab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01561	Nivolumab;Padnarsertib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01561	Nivolumab;Padnarsertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01562	Nivolumab;PBF1129	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01563	Nivolumab;Pegilodecakin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01564	Nivolumab;Pepinemab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01565	Nivolumab;Pexmetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01566	Nivolumab;Plozalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01567	Nivolumab;Pomalidomide	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01568	Nivolumab;Pulrodemstat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01569	Nivolumab;Ragifilimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01570	Nivolumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01571	Nivolumab;Ramucirumab;TRK950	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01571	Nivolumab;Ramucirumab;TRK950	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01572	Nivolumab;Regorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01572	Nivolumab;Regorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC01573	Nivolumab;Relatlimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01573	Nivolumab;Relatlimab	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC01573	Nivolumab;Relatlimab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC01573	Nivolumab;Relatlimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC01573	Nivolumab;Relatlimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Approval
DC01574	Nivolumab;Rigosertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01575	Nivolumab;Rucaparib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01575	Nivolumab;Rucaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01575	Nivolumab;Rucaparib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01575	Nivolumab;Rucaparib	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC01576	Nivolumab;Ruxolitinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01577	Nivolumab;RXC004	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01578	Nivolumab;Selinexor	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01579	Nivolumab;SF1126	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01580	Nivolumab;Sitravatinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01580	Nivolumab;Sitravatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01581	Nivolumab;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01582	Nivolumab;Sotigalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01582	Nivolumab;Sotigalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01583	Nivolumab;Sym004	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01584	Nivolumab;Talazoparib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01585	Nivolumab;Telaglenastat	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC01585	Nivolumab;Telaglenastat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01585	Nivolumab;Telaglenastat	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01586	Nivolumab;Telisotuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01587	Nivolumab;Tivozanib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 3
DC01588	Nivolumab;Tovorafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01589	Nivolumab;TPST1120	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01590	Nivolumab;Trastuzumab Deruxtecan	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC01590	Nivolumab;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01591	Nivolumab;Trastuzumab imbotolimod	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01592	Nivolumab;TRK950	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01592	Nivolumab;TRK950	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01593	Nivolumab;TRX518	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01594	Nivolumab;Tucidinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01595	Nivolumab;Ulocuplumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01596	Nivolumab;Urelumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01596	Nivolumab;Urelumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01597	Nivolumab;Varlilumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01598	Nivolumab;Vidutolimod	DrugComb	FD00026	Melanoma	Melanoma	Phase 2|Phase 3
DC01599	Nivolumab;Vopratelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01600	Nivolumab;Vorolanib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01600	Nivolumab;Vorolanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01600	Nivolumab;Vorolanib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01600	Nivolumab;Vorolanib	DrugComb	FD00042	Thymic Carcinoma	Other Cancer	Phase 1|Phase 2
DC01601	Nivolumab;XB002	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01602	Nivolumab;Xevinapant	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01603	Nivolumab;Zanzalintinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01603	Nivolumab;Zanzalintinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01604	Numidargistat;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01605	NZV930;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01606	NZV930;Spartalizumab;Taminadenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01607	NZV930;Taminadenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01608	Obatoclax;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01609	Obinutuzumab;Sacituzumab Govitecan	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01610	Obinutuzumab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 3
DC01610	Obinutuzumab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01611	Obinutuzumab;Zanubrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01612	Obrindatamab;Retifanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01612	Obrindatamab;Retifanlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01613	Ociperlimab;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01613	Ociperlimab;Tislelizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01614	Ofatumumab;Ofatumumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01615	Olaparib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01615	Olaparib;Pembrolizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01615	Olaparib;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01615	Olaparib;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01615	Olaparib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01616	Olaparib;Prexasertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01617	Olaparib;Selumetinib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01618	Olaparib;Tremelimumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01619	Olaratumab;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01620	Oleclumab;Osimertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01621	Olinvacimab;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01621	Olinvacimab;Pembrolizumab	DrugComb	FD00017	Glioma	Glioma	Phase 1
DC01622	Onartuzumab;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01623	Onatasertib;Rituximab;Spebrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01624	Onatasertib;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01625	Opnurasib;Ribociclib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01626	Opnurasib;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01627	Opnurasib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01628	Oprozomib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01629	Osimertinib;Patritumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01630	Osimertinib;Patritumab Deruxtecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01631	Osimertinib;Pelcitoclax	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01632	Osimertinib;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01633	Osimertinib;Repotrectinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01634	Osimertinib;Sapanisertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01635	Osimertinib;Savolitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01636	Osimertinib;Selpercatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01637	Osimertinib;Selumetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01638	Osimertinib;SKB264	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01639	Osimertinib;Tegavivint	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01640	Osimertinib;Telaglenastat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01641	Osimertinib;Telisotuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01642	Osimertinib;Tepotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01643	Osimertinib;Tigozertinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01644	Osimertinib;Tipifarnib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01645	Osimertinib;TQ-B3525	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01646	Osimertinib;Trastuzumab Emtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01647	Osimertinib;Vebreltinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01648	Osimertinib;VIC1911	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01649	Pacmilimab;Praluzatamab Ravtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01650	Palbociclib;Retifanlimab	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01651	Palbociclib;Rintodestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01652	Palbociclib;SCR6852	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01653	Palbociclib;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01654	Palbociclib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01655	Palbociclib;Taragarestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01656	Palbociclib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01657	Palbociclib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01658	Palbociclib;Ulixertinib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01658	Palbociclib;Ulixertinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01659	Palbociclib;ZB716	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01660	Palbociclib;ZN-c5	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01661	Palupiprant;Pembrolizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01662	Pamiparib;Sulfatinib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01663	Pamiparib;Tamoxifen	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01664	Pamiparib;Tislelizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01665	Pamufetinib;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01666	Panitumumab;Regorafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01667	Panitumumab;Rilotumumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01667	Panitumumab;Rilotumumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01668	Panitumumab;Sirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01669	Panobinostat;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01670	Panobinostat;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01671	Panobinostat;Sorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01672	Panobinostat;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01672	Panobinostat;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01673	Panobinostat;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01674	Parsaclisib;Pembrolizumab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01675	Parsaclisib;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01676	Parsaclisib;Ruxolitinib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC01677	Parsaclisib;Tafasitamab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01677	Parsaclisib;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01678	Parsaclisib;Tucidinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01679	Parsaclisib;Uzansertib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01680	Parsatuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01681	Pavunalimab;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01682	Pavurutamab;Pomalidomide	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01683	Paxalisib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01684	Pazopanib;Pegilodecakin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01685	Pazopanib;Temsirolimus	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01686	Pazopanib;Trametinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01687	Pazopanib;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01688	PC14586;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01689	Pegcrisantaspase;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01690	Pegenzileukin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01690	Pegenzileukin;Pembrolizumab	DrugComb	FD00037	Pleural Mesothelioma	Other Cancer	Phase 2
DC01691	Pegilodecakin;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01692	Pelcitoclax;Tucidinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01693	Pembrolizumab;Pemigatinib	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC01693	Pembrolizumab;Pemigatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01693	Pembrolizumab;Pemigatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01694	Pembrolizumab;Pevonedistat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01695	Pembrolizumab;Pexidartinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01696	Pembrolizumab;Plerixafor	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01697	Pembrolizumab;Preladenant	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01698	Pembrolizumab;Q702	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC01698	Pembrolizumab;Q702	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01698	Pembrolizumab;Q702	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01698	Pembrolizumab;Q702	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01699	Pembrolizumab;Quavonlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01700	Pembrolizumab;Ramucirumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01700	Pembrolizumab;Ramucirumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01700	Pembrolizumab;Ramucirumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01700	Pembrolizumab;Ramucirumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01701	Pembrolizumab;Ramucirumab;Tusamitamab Ravtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01702	Pembrolizumab;Relacorilant	DrugComb	FD00001	Adrenocortical Carcinoma	Other Cancer	Phase 1
DC01703	Pembrolizumab;Rituximab;Tinostamustine	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01704	Pembrolizumab;RMC6236	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01705	Pembrolizumab;RMC6291	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01706	Pembrolizumab;Romidepsin	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01707	Pembrolizumab;Rucaparib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01708	Pembrolizumab;Ruxolitinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01709	Pembrolizumab;S531011	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01710	Pembrolizumab;Sacituzumab Govitecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01711	Pembrolizumab;Sacituzumab Tirumotecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01712	Pembrolizumab;SBT6290	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01713	Pembrolizumab;Selinexor	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01713	Pembrolizumab;Selinexor	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01713	Pembrolizumab;Selinexor	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01714	Pembrolizumab;Selumetinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01715	Pembrolizumab;Simlukafusp Alfa	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01716	Pembrolizumab;Sirexatamab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC01716	Pembrolizumab;Sirexatamab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01716	Pembrolizumab;Sirexatamab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01717	Pembrolizumab;Sitravatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01717	Pembrolizumab;Sitravatinib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01718	Pembrolizumab;SKB264	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01719	Pembrolizumab;SLC391	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01720	Pembrolizumab;Sonidegib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01721	Pembrolizumab;Sotigalimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01722	Pembrolizumab;Sotorasib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01723	Pembrolizumab;ST-067	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01724	Pembrolizumab;STK012	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01725	Pembrolizumab;Subasumstat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01726	Pembrolizumab;SX682	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01727	Pembrolizumab;TAK500	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01728	Pembrolizumab;Tazemetostat	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01729	Pembrolizumab;Tebentafusp	DrugComb	FD00026	Melanoma	Melanoma	Phase 2|Phase 3
DC01730	Pembrolizumab;Tecaginlimab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01730	Pembrolizumab;Tecaginlimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01730	Pembrolizumab;Tecaginlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01730	Pembrolizumab;Tecaginlimab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01730	Pembrolizumab;Tecaginlimab	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC01731	Pembrolizumab;Telatinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01731	Pembrolizumab;Telatinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01732	Pembrolizumab;Tenalisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01733	Pembrolizumab;Tepotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01734	Pembrolizumab;Tilarginine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01734	Pembrolizumab;Tilarginine	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01735	Pembrolizumab;Tisotumab Vedotin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01735	Pembrolizumab;Tisotumab Vedotin	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC01736	Pembrolizumab;Tivumecirnon	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01736	Pembrolizumab;Tivumecirnon	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01737	Pembrolizumab;TNG260	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01738	Pembrolizumab;Tolinapant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01738	Pembrolizumab;Tolinapant	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC01739	Pembrolizumab;Tomivosertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01740	Pembrolizumab;TPST1495	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01741	Pembrolizumab;TransCon IL-2 beta/gamma	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01741	Pembrolizumab;TransCon IL-2 beta/gamma	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01742	Pembrolizumab;TransCon TLR7/8 Agonist	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01743	Pembrolizumab;Trastuzumab	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Approval
DC01743	Pembrolizumab;Trastuzumab	DrugComb	FD00026	Melanoma	Melanoma	Approval
DC01743	Pembrolizumab;Trastuzumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC01743	Pembrolizumab;Trastuzumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC01743	Pembrolizumab;Trastuzumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Approval
DC01744	Pembrolizumab;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01744	Pembrolizumab;Trastuzumab Deruxtecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01745	Pembrolizumab;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01746	Pembrolizumab;Trastuzumab;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01746	Pembrolizumab;Trastuzumab;Tucatinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01747	Pembrolizumab;Trebananib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01748	Pembrolizumab;TRK950	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01748	Pembrolizumab;TRK950	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01749	Pembrolizumab;TRX518	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01750	Pembrolizumab;TTI101	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01751	Pembrolizumab;TTX030	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01751	Pembrolizumab;TTX030	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01752	Pembrolizumab;TTX080	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01753	Pembrolizumab;TU2218	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01754	Pembrolizumab;Tucidinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01755	Pembrolizumab;Tusamitamab Ravtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01756	Pembrolizumab;Ulevostinag	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01756	Pembrolizumab;Ulevostinag	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01756	Pembrolizumab;Ulevostinag	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01757	Pembrolizumab;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01757	Pembrolizumab;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01758	Pembrolizumab;Utomilumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01759	Pembrolizumab;Vactosertib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01759	Pembrolizumab;Vactosertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01759	Pembrolizumab;Vactosertib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01759	Pembrolizumab;Vactosertib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC01760	Pembrolizumab;Valemetostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01761	Pembrolizumab;Venetoclax	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01762	Pembrolizumab;Vibostolimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01763	Pembrolizumab;Vicriviroc	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01764	Pembrolizumab;Vidutolimod	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01764	Pembrolizumab;Vidutolimod	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01765	Pembrolizumab;Vodudeutentan	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01766	Pembrolizumab;Vofatamab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC01767	Pembrolizumab;Vopratelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01768	Pembrolizumab;Vorasidenib	DrugComb	FD00004	Astrocytoma	Other Cancer	Phase 1
DC01769	Pembrolizumab;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01770	Pembrolizumab;Vorolanib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01770	Pembrolizumab;Vorolanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01770	Pembrolizumab;Vorolanib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC01771	Pembrolizumab;W0180	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01772	Pembrolizumab;WM-A1-3389	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01773	Pembrolizumab;WTX124	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01774	Pembrolizumab;Xevinapant	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01774	Pembrolizumab;Xevinapant	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01775	Pembrolizumab;XmAb808	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01776	Pembrolizumab;XNW5004	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01777	Pembrolizumab;XTX101	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01778	Pembrolizumab;YH001;YH003	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01779	Pembrolizumab;Zalifrelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01780	Pembrolizumab;Zelenectide Pevedotin	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01781	Pembrolizumab;ZL1218	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01782	Pembrolizumab;Zolbetuximab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01783	Pembrolizumab;Zotiraciclib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01784	Pemigatinib;Retifanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01784	Pemigatinib;Retifanlimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01784	Pemigatinib;Retifanlimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01785	Pemigatinib;Sintilimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01786	Pemigatinib;Trastuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01787	Penpulimab;TQB2223	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01788	Penpulimab;TQB2618	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01788	Penpulimab;TQB2618	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01789	Penpulimab;TQB2618;TQB3617	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC01790	Penpulimab;TQB3602	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01791	Perifosine;Sorafenib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01792	Perifosine;Sunitinib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01792	Perifosine;Sunitinib	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1
DC01793	Pertuzumab Zuvotolimod;Trastuzumab Deruxtecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01794	Pertuzumab Zuvotolimod;Trastuzumab;Tucatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01795	Pertuzumab;Pertuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01796	Pertuzumab;Tocilizumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01797	Pertuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01797	Pertuzumab;Trastuzumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01798	Pertuzumab;Trastuzumab Deruxtecan	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01799	Pertuzumab;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01799	Pertuzumab;Trastuzumab Emtansine	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01800	Pertuzumab;Trastuzumab;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01801	Pertuzumab;Trastuzumab;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01802	Pexidartinib;Sirolimus	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC01803	Pexidartinib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01804	PF06940434;Sasanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01805	PF07265028;Sasanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01806	PF07799544;Tinlorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01807	Phesgo;ZN-A-1041	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01808	Pidilizumab;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01809	Pilaralisib;Tesevatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01810	Pilaralisib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01811	Pimasertib;SAR405838	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01812	Pimasertib;Tovorafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01813	Pimasertib;Voxtalisib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01814	Pimitespib;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01815	Pimivalimab;Polzastobart	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01816	Pimivalimab;Vopratelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01817	Pimurutamab;Serplulimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01818	Pinatuzumab Vedotin;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01818	Pinatuzumab Vedotin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01819	Pirtobrutinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01819	Pirtobrutinib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01820	Plamotamab;Tafasitamab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01821	Polatuzumab Vedotin;Rituximab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01821	Polatuzumab Vedotin;Rituximab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01822	Polatuzumab Vedotin;Rituximab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01823	Polatuzumab Vedotin;Vanucizumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01824	Pomalidomide;Vactosertib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01825	Pomalidomide;Vedolizumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01826	Ponatinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01827	Porustobart;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01828	Prexasertib;Ralimetinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01828	Prexasertib;Ralimetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01829	Prexasertib;Samotolisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01829	Prexasertib;Samotolisib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01830	PSB205;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01831	PY159;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01832	PY314;Pembrolizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01833	Pyrotinib;Trastuzumab	DrugComb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC01834	Pyrotinib;Trastuzumab Rezetecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01835	QBM076;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01836	Quemliclustat;Zimberelimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01837	Quizartinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01838	Ragifilimab;Retifanlimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01839	Ralimetinib;Ralimetinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01839	Ralimetinib;Ralimetinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01840	Ralimetinib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01841	Ralzapastotug;Zimberelimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01842	Ramucirumab;Sintilimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 3
DC01843	Ramucirumab;Tusamitamab Ravtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01844	RC88;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01845	Refametinib;Sorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01846	Regorafenib;Spartalizumab	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01847	Regorafenib;Sugemalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01848	Regorafenib;Tucidinostat	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01849	Repotrectinib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01850	Resminostat;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01851	Retaspimycin;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01852	Retifanlimab;Ruxolitinib;Trametinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01853	Retifanlimab;Vobramitamab Duocarmazine	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01854	Revdofilimab;Tilsotolimod	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01855	Ribociclib;Siremadlin	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01855	Ribociclib;Siremadlin	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1
DC01856	Ribociclib;Sonidegib	DrugComb	FD00025	Medulloblastoma	Other Cancer	Phase 1
DC01857	Ribociclib;Spartalizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01858	Ribociclib;Tamoxifen	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01859	Ribociclib;Trametinib	DrugComb	FD00025	Medulloblastoma	Other Cancer	Phase 1
DC01859	Ribociclib;Trametinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01860	Ribociclib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01861	Ribociclib;Trastuzumab Emtansine	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01862	Ribociclib;Vepdegestrant	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01863	Ridaforolimus;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01864	Rituximab;Spebrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01864	Rituximab;Spebrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01865	Rituximab;Subasumstat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01866	Rituximab;Tazemetostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01867	Rituximab;Tiragolumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01867	Rituximab;Tiragolumab	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01868	Rituximab;TL011	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01869	Rituximab;TQB2303	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01870	Rituximab;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01871	Rituximab;Urelumab	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01871	Rituximab;Urelumab	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01872	Rituximab;Utomilumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01873	Rituximab;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01873	Rituximab;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01874	Rituximab;Venetoclax;Zandelisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01875	Rituximab;Vistusertib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01876	Rituximab;Zandelisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC01877	Rituximab;Zanubrutinib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC01877	Rituximab;Zanubrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01878	Rivoceranib;Sintilimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01879	RMC6236;RMC6291	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01880	Rociletinib;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01881	Romidepsin;Tenalisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01882	Ruxolitinib;Sonidegib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01883	Ruxolitinib;TL895	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01884	Ruxolitinib;Trametinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01884	Ruxolitinib;Trametinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC01885	Ruxolitinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01886	Ruxolitinib;Uzansertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01887	Ruxolitinib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01888	Ruxolitinib;Zelavespib	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01889	Sapanisertib;Serabelisib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01889	Sapanisertib;Serabelisib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01889	Sapanisertib;Serabelisib	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01890	Sapanisertib;Telaglenastat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01891	SAR260301;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01892	Saruparib;Trastuzumab Deruxtecan	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01893	SEA-TGT;Sasanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01894	Selicrelumab;Vanucizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01895	Selinexor;Sorafenib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01896	Selumetinib;Sirolimus	DrugComb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC01897	Selumetinib;Temsirolimus	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01898	Selumetinib;Vandetanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01899	Selumetinib;Vistusertib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01900	Sintilimab;Sulfatinib	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC01900	Sintilimab;Sulfatinib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC01900	Sintilimab;Sulfatinib	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01901	Sintilimab;Tamgiblimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01902	Sintilimab;Tucidinostat	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01902	Sintilimab;Tucidinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01902	Sintilimab;Tucidinostat	DrugComb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC01903	Sintilimab;Tusamitamab Ravtansine	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01904	Sintilimab;YL13027	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01905	Siremadlin;Spartalizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01906	Siremadlin;Trametinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC01907	Siremadlin;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01907	Siremadlin;Venetoclax	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01908	Sirolimus;Sorafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01909	Sirolimus;Sunitinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01910	Sirolimus;Vismodegib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01911	Sirolimus;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01912	Sitravatinib;Tislelizumab	DrugComb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC01912	Sitravatinib;Tislelizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC01912	Sitravatinib;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC01912	Sitravatinib;Tislelizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01912	Sitravatinib;Tislelizumab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01913	SKB264;Tagitanlimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01914	Sonolisib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01915	Sorafenib;Sorafenib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01916	Sorafenib;Spartalizumab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01917	Sorafenib;Temsirolimus	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01917	Sorafenib;Temsirolimus	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01918	Sorafenib;Tivantinib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01919	Sorafenib;Toripalimab	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC01920	Sorafenib;Trametinib	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC01921	Sorafenib;Vemurafenib	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC01922	Sorafenib;Vorinostat	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01922	Sorafenib;Vorinostat	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01922	Sorafenib;Vorinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01922	Sorafenib;Vorinostat	DrugComb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC01923	Sotorasib;Tarloxotinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01924	Sotorasib;VIC1911	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01925	Sotorasib;Vociprotafib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01926	Sotorasib;Zeluvalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01927	Sotuletinib;Spartalizumab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01928	Spartalizumab;Taminadenant	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01928	Spartalizumab;Taminadenant	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01928	Spartalizumab;Taminadenant	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01929	Spartalizumab;Trametinib	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01929	Spartalizumab;Trametinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01930	Sulfatinib;Tislelizumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01931	Sulfatinib;Toripalimab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01931	Sulfatinib;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 2
DC01931	Sulfatinib;Toripalimab	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01931	Sulfatinib;Toripalimab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01932	Sunitinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01933	Sunitinib;Trebananib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01934	Surzebiclimab;Tislelizumab	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC01934	Surzebiclimab;Tislelizumab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01935	Sym021;Sym022	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01936	Sym021;Sym022;Sym023	DrugComb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC01936	Sym021;Sym022;Sym023	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01937	Sym021;Sym023	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01938	Sym021;Sym024	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01939	TAB006;Toripalimab	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01940	Talazoparib;Tazemetostat	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01941	Talazoparib;Telaglenastat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01941	Talazoparib;Telaglenastat	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC01942	Talazoparib;ZEN003694	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01942	Talazoparib;ZEN003694	DrugComb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC01943	Tamoxifen;Taselisib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01944	Tamoxifen;Tipifarnib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01945	Tamoxifen;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01946	Tapotoclax;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01946	Tapotoclax;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01947	Tarlatamab;Zeluvalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01948	Tazemetostat;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01949	Tazemetostat;Zandelisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC01950	Tebentafusp;Tremelimumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01951	Temsirolimus;Tivozanib	DrugComb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01952	Temsirolimus;Trebananib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01953	Temsirolimus;Vemurafenib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01954	Temsirolimus;Vorinostat	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01954	Temsirolimus;Vorinostat	DrugComb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC01955	Temuterkib;Vociprotafib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01956	Tesevatinib;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01957	Tifcemalimab;Toripalimab	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01958	Tislelizumab;Trastuzumab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01959	Tislelizumab;Tucidinostat	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01960	Tislelizumab;Zanidatamab	DrugComb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC01961	Tislelizumab;Zanubrutinib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01962	Tofacitinib;Tucidinostat	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01963	Toripalimab;Vorolanib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01963	Toripalimab;Vorolanib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01964	Toripalimab;YH001	DrugComb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC01964	Toripalimab;YH001	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01965	Toripalimab;YH003	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01965	Toripalimab;YH003	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01965	Toripalimab;YH003	DrugComb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC01966	Toripalimab;YH004	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01967	TQB2618;Teriprizumab	DrugComb	FD00026	Melanoma	Melanoma	Phase 1
DC01968	Trametinib;Uprosertib	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01969	Trametinib;XP102	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC01969	Trametinib;XP102	DrugComb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC01969	Trametinib;XP102	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01969	Trametinib;XP102	DrugComb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC01970	TransCon IL-2 beta/gamma;TransCon TLR7/8 Agonist	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC01970	TransCon IL-2 beta/gamma;TransCon TLR7/8 Agonist	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01971	Trastuzumab Deruxtecan;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC01972	Trastuzumab Deruxtecan;Valemetostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01973	Trastuzumab Deruxtecan;Volrustomig	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01974	Trastuzumab Deruxtecan;ZN-A-1041	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01975	Trastuzumab Emtansine;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01975	Trastuzumab Emtansine;Tucatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01976	Trastuzumab Emtansine;Utomilumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC01977	Trastuzumab Emtansine;ZN-A-1041	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01978	Trastuzumab;Trastuzumab	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 3
DC01979	Trastuzumab;Tucatinib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Approval
DC01979	Trastuzumab;Tucatinib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Approval
DC01979	Trastuzumab;Tucatinib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01980	Trastuzumab;Vatalanib	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01981	Trastuzumab;Vorinostat	DrugComb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC01982	Tretinoin;Vandetanib	DrugComb	FD00031	Neuroblastoma	Other Cancer	Phase 1
DC01983	Tunlametinib;Vemurafenib	DrugComb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC01983	Tunlametinib;Vemurafenib	DrugComb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01983	Tunlametinib;Vemurafenib	DrugComb	FD00026	Melanoma	Melanoma	Phase 2
DC01984	Ublituximab;Umbralisib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2|Phase 3
DC01984	Ublituximab;Umbralisib	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2|Phase 3
DC01985	Ublituximab;Umbralisib;Venetoclax	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 2|Phase 3
DC01985	Ublituximab;Umbralisib;Venetoclax	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2|Phase 3
DC01986	Ublituximab;Zeripatamig	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01986	Ublituximab;Zeripatamig	DrugComb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01987	Venetoclax;Voruciclib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01988	Venetoclax;Ziftomenib	DrugComb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01989	WX037;WX554	DrugComb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01990	4G7xH22	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01990	4G7xH22	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01991	6MW3211	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC01991	6MW3211	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC01991	6MW3211	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC01991	6MW3211	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC01991	6MW3211	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01991	6MW3211	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01992	6MW3511	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01993	A319	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC01994	AB248	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC01994	AB248	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC01994	AB248	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01994	AB248	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC01995	ABBV184	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC01995	ABBV184	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC01996	ABBV383	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC01997	ABBV428	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC01998	ABL001	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC01999	ABL105	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02000	ABL501	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02001	ABL503	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02002	Acapatamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02002	Acapatamab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC02003	Acasunlimab	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC02003	Acasunlimab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02003	Acasunlimab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02003	Acasunlimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02003	Acasunlimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC02004	Acimtamig	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC02004	Acimtamig	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC02005	AFM11	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02005	AFM11	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02006	AFM24	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02006	AFM24	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02006	AFM24	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02007	AFM28	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02008	AGEN1223	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02009	AK129	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02010	AK130	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02011	Alnuctamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02012	AMG211	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02013	AMG340	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02014	AMG424	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02015	AMG427	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02016	AMG509	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02017	AMG562	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02018	AMG794	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02018	AMG794	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02019	Amivantamab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02019	Amivantamab	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02019	Amivantamab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02019	Amivantamab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02019	Amivantamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Approval
DC02019	Amivantamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02019	Amivantamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02020	AMX-818	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02021	Anbenitamab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02021	Anbenitamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02021	Anbenitamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 2
DC02022	AP203	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC02022	AP203	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02022	AP203	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02023	APVO436	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02023	APVO436	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02024	ARB202	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02024	ARB202	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02024	ARB202	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02024	ARB202	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02025	ASP2138	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02025	ASP2138	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02026	ATG101	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02026	ATG101	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02027	ATOR1015	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02028	AZD7789	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02028	AZD7789	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02029	AZD9592	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02029	AZD9592	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02030	B1962	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02031	BA1202	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02032	BA3182	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02033	Bafisontamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02033	Bafisontamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02034	BAT7104	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02035	BCA101	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02036	BCD147	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02037	BGBB167	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02038	BI764532	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02038	BI764532	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02038	BI764532	BsAb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 1|Phase 2
DC02039	BI765049	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02039	BI765049	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02039	BI765049	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02039	BI765049	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02039	BI765049	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02040	BI765179	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02041	BI836880	BsAb	FD00002	Anal Cancer	Other Cancer	Phase 2
DC02041	BI836880	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02041	BI836880	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02041	BI836880	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02041	BI836880	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02042	BI905677	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02043	BI905711	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02043	BI905711	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02043	BI905711	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02044	Bintrafusp Alfa	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2|Phase 3
DC02044	Bintrafusp Alfa	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02044	Bintrafusp Alfa	BsAb	FD00031	Neuroblastoma	Other Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00033	Other Cancer	Other Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02044	Bintrafusp Alfa	BsAb	FD00042	Thymic Carcinoma	Other Cancer	Phase 2
DC02045	BJ005	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02045	BJ005	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02046	BLB01D1	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02046	BLB01D1	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02046	BLB01D1	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02047	Blinatumomab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 2
DC02047	Blinatumomab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Approval
DC02047	Blinatumomab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 3
DC02047	Blinatumomab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Early Phase 1
DC02048	BLYG8824A	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02049	BNT142	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02050	BPB101	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02051	BT7480	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02052	Cadonilimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02052	Cadonilimab	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02052	Cadonilimab	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02052	Cadonilimab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 3
DC02052	Cadonilimab	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC02052	Cadonilimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 3
DC02052	Cadonilimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02052	Cadonilimab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02052	Cadonilimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02052	Cadonilimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02052	Cadonilimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Approval
DC02052	Cadonilimab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC02052	Cadonilimab	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC02052	Cadonilimab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 3
DC02052	Cadonilimab	BsAb	FD00043	Vulvar Cancer	Other Cancer	Phase 2
DC02053	Catumaxomab	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC02053	Catumaxomab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02053	Catumaxomab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 3
DC02053	Catumaxomab	BsAb	FD00047	Malignant Ascites	Other Cancer	Approval
DC02054	CBP1008	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02055	CBP1018	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02056	CC-1	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02056	CC-1	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02057	CC-3	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02058	CCW702	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02059	CDX527	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02060	CDX585	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02061	Cergutuzumab Amunaleukin	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02062	Cevostamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC02063	Cibisatamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02063	Cibisatamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02064	Cinrebafusp Alfa	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC02064	Cinrebafusp Alfa	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02064	Cinrebafusp Alfa	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02065	CKD702	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02065	CKD702	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02066	CLN049	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02066	CLN049	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02067	CLN978	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02068	CM336	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC02069	CM350	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02070	CM355	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02071	CN201	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02072	CPO107	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02073	CVX241	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02074	CX904	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02075	D2C7IT	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02076	Dalutrafusp Alfa	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02076	Dalutrafusp Alfa	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC02077	Davoceticept	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02078	Davutamig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02079	Dilpacimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02079	Dilpacimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02080	DSP107	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02080	DSP107	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02080	DSP107	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02080	DSP107	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02081	DT2219ARL	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02081	DT2219ARL	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02082	Duligotuzumab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02083	Duvortuxizumab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02083	Duvortuxizumab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02084	DYP688	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02085	Eciskafusp Alfa	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02086	Elranatamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC02087	Eluvixtamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02087	Eluvixtamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02088	EMB02	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02089	EMB06	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC02090	EMB07	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02091	EMB09	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02092	Emerfetamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Early Phase 1
DC02093	Enristomig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02094	Ensomafusp Alfa	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02095	Epcoritamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02095	Epcoritamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC02096	Eramkafusp Alfa	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02097	Erfonrilimab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02097	Erfonrilimab	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02097	Erfonrilimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02097	Erfonrilimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02097	Erfonrilimab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02097	Erfonrilimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 2
DC02097	Erfonrilimab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 3
DC02097	Erfonrilimab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02097	Erfonrilimab	BsAb	FD00042	Thymic Carcinoma	Other Cancer	Phase 2
DC02098	Ertumaxomab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02098	Ertumaxomab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02099	ERY974	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02099	ERY974	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02100	ES014	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02101	ES414	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02102	Etevritamab	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02103	EX103	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02104	F182112	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02105	FBTA05	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02106	Fidasimtamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02106	Fidasimtamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02107	Flotetuzumab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 2
DC02107	Flotetuzumab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC02107	Flotetuzumab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC02108	FS118	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02109	FS120	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02110	FS222	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02111	GB261	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02111	GB261	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02112	GBR1302	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02112	GBR1302	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02113	GEM333	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02114	GEM3PSCA	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1
DC02114	GEM3PSCA	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC02114	GEM3PSCA	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02114	GEM3PSCA	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02115	GEN1044	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02116	GEN1047	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02116	GEN1047	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02116	GEN1047	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02117	GI101	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC02118	GI102	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02119	Givastomig	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC02119	Givastomig	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02120	Glofitamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC02121	GNR084	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02122	Gresonitamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02123	HB002T	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02124	HB0036	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02125	HBM7008	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02126	HCW9218	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02126	HCW9218	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC02127	HLX301	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02127	HLX301	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02127	HLX301	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02128	HLX35	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02129	HX009	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02129	HX009	BsAb	FD00033	Other Cancer	Other Cancer	Phase 2
DC02130	IBI318	BsAb	FD00012	Cutaneous Squamous Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC02130	IBI318	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02130	IBI318	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02130	IBI318	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02130	IBI318	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02131	IBI319	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02132	IBI321	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02133	IBI323	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02133	IBI323	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02134	IBI334	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02135	IBI363	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02135	IBI363	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02136	IBI389	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02137	IGM2644	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02138	IGM7354	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02139	IMA401	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02140	IMCC103C	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02141	IMCF106C	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02142	IMM0306	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02143	IMM2520	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02143	IMM2520	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02143	IMM2520	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02143	IMM2520	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02144	IMM2902	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC02144	IMM2902	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02144	IMM2902	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02145	Imvotamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02146	INCA32459	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02147	Inezetamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02148	ISB1342	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02149	ISB1442	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC02150	Istiratumab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02150	Istiratumab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02150	Istiratumab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02150	Istiratumab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02150	Istiratumab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC02151	Ivicentamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02152	Ivonescimab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02152	Ivonescimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02152	Ivonescimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02152	Ivonescimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02152	Ivonescimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02152	Ivonescimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02153	Izalontamab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02153	Izalontamab	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02153	Izalontamab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02153	Izalontamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02153	Izalontamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02154	Izuralimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02154	Izuralimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02154	Izuralimab	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC02155	JK08	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02155	JK08	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02155	JK08	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02156	JNJ63709178	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02157	JNJ67571244	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02157	JNJ67571244	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02158	JNJ70218902	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02159	JNJ75348780	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02160	JNJ78278343	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02161	JNJ78306358	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02162	JS201	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02162	JS201	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02163	JS203	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02164	JSKN003	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02165	KM257	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02166	KM501	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02167	KN052	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02168	Latikafusp	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02169	LB101	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02170	LB1410	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02170	LB1410	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02171	LB4330	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02172	LBL015	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02173	LBL024	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02174	LBL033	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02175	Linvoseltamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 3
DC02176	Lomvastomig	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02176	Lomvastomig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02176	Lomvastomig	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02177	Lorigerlimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02177	Lorigerlimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02177	Lorigerlimab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02178	LX039	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02179	LY3164530	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02180	LY3415244	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02181	M1231	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC02181	M1231	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02182	M701	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02182	M701	BsAb	FD00047	Malignant Ascites	Other Cancer	Phase 1
DC02183	M802	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02184	MBS301	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02185	MBS303	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1|Phase 2
DC02186	MCLA129	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02186	MCLA129	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1|Phase 2
DC02186	MCLA129	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02186	MCLA129	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02186	MCLA129	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02187	MCLA145	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02187	MCLA145	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02188	MCLA158	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02188	MCLA158	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02188	MCLA158	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02188	MCLA158	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02189	MDX447	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02190	MEDI4276	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02190	MEDI4276	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02191	MGD007	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02192	MGD024	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02193	MM111	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02193	MM111	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02193	MM111	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02193	MM111	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02194	Mosunetuzumab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1|Phase 2
DC02194	Mosunetuzumab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02194	Mosunetuzumab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Approval
DC02195	MP0250	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02196	MP0310	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02197	MP0317	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02198	Navicixizumab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02198	Navicixizumab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02198	Navicixizumab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02198	Navicixizumab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 3
DC02198	Navicixizumab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02199	Nezastomig	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC02200	NG641	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02200	NG641	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02201	NGM707	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02202	NI1801	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02202	NI1801	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02202	NI1801	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02203	Nivatrotamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02203	Nivatrotamab	BsAb	FD00031	Neuroblastoma	Other Cancer	Phase 1|Phase 2
DC02203	Nivatrotamab	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1|Phase 2
DC02204	NVG111	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02204	NVG111	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02205	Obrindatamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02205	Obrindatamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02206	Odronextamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02206	Odronextamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC02207	ONO4685	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02208	Pacanalotamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02209	Pasotuxizumab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02210	Pavunalimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02210	Pavunalimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02211	Pavurutamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02212	PF04856884	BsAb	FD00017	Glioma	Glioma	Phase 2
DC02212	PF04856884	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC02213	PF06671008	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02214	PF07062119	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02214	PF07062119	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 1
DC02214	PF07062119	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02215	PF07257876	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1
DC02215	PF07257876	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02215	PF07257876	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02216	PF07260437	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02216	PF07260437	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02217	Plamotamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02217	Plamotamab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 2
DC02218	PM1003	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02219	PM1009	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02220	PM1022	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02221	PM1032	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02222	PM8001	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02223	PM8002	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1|Phase 2
DC02223	PM8002	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02223	PM8002	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2|Phase 3
DC02223	PM8002	BsAb	FD00029	Mesothelioma	Other Cancer	Phase 2
DC02223	PM8002	BsAb	FD00032	Neuroendocrine Tumor	Other Cancer	Phase 2
DC02224	PRS344	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02225	PRV3279	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02226	PSB205	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02227	PT217	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02228	PT886	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC02228	PT886	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1|Phase 2
DC02229	Q1802	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02230	QLF31907	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC02230	QLF31907	BsAb	FD00026	Melanoma	Melanoma	Phase 2
DC02230	QLF31907	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02231	QLS31901	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02232	QLS31904	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02233	QLS31905	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02234	QLS32015	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02235	REGN4336	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1|Phase 2
DC02236	REGN5459	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC02237	REGN5668	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC02238	REGN5837	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02239	REGN7075	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02240	Reozalimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02241	Retlirafusp Alfa	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02241	Retlirafusp Alfa	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02242	Rilvegostomig	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02242	Rilvegostomig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02242	Rilvegostomig	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02243	RO7122290	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02244	RO7293583	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02245	RO7297089	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02246	RO7300490	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02247	RO7428731	BsAb	FD00017	Glioma	Glioma	Phase 1
DC02248	RO7443904	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02249	RO7444973	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02250	Runimotamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02251	SAIL66	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02252	SAR440234	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1|Phase 2
DC02252	SAR440234	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1|Phase 2
DC02253	SAR445710	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02254	SAR445877	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02255	SC004	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02255	SC004	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02256	SG1906	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02257	SG2501	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02258	SGNBB228	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02258	SGNBB228	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02258	SGNBB228	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02258	SGNBB228	BsAb	FD00029	Mesothelioma	Other Cancer	Phase 1
DC02258	SGNBB228	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02259	SHR2002	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02259	SHR2002	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02260	SHR7367	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02261	SI-B003	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02261	SI-B003	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02262	SIM0348	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02263	Simlukafusp Alfa	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02263	Simlukafusp Alfa	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02263	Simlukafusp Alfa	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC02263	Simlukafusp Alfa	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02263	Simlukafusp Alfa	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02263	Simlukafusp Alfa	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02264	Simridarlimab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02264	Simridarlimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02264	Simridarlimab	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02264	Simridarlimab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02265	Solitomab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02266	Sotiburafusp Alfa	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02267	SSGJ705	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02268	TAK186	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02268	TAK186	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02268	TAK186	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02269	TAK500	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02270	Talquetamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC02271	Tarlatamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02271	Tarlatamab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02272	Tebentafusp	BsAb	FD00026	Melanoma	Melanoma	Approval
DC02273	Tebotelimab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02273	Tebotelimab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2|Phase 3
DC02273	Tebotelimab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02273	Tebotelimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC02273	Tebotelimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02273	Tebotelimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1
DC02273	Tebotelimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02273	Tebotelimab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2|Phase 3
DC02274	Tecaginlimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1|Phase 2
DC02274	Tecaginlimab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02274	Tecaginlimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02274	Tecaginlimab	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02274	Tecaginlimab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1|Phase 2
DC02275	Teclistamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Approval
DC02276	Tepoditamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02277	Tidutamab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1|Phase 2
DC02277	Tidutamab	BsAb	FD00028	Merkel Cell Carcinoma	Other Cancer	Phase 1|Phase 2
DC02277	Tidutamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02278	TNB486	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02279	Tobemstomig	BsAb	FD00006	Bladder Cancer	Bladder Cancer	Phase 2
DC02279	Tobemstomig	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02279	Tobemstomig	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 2
DC02279	Tobemstomig	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 2
DC02279	Tobemstomig	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 1|Phase 2
DC02279	Tobemstomig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02279	Tobemstomig	BsAb	FD00026	Melanoma	Melanoma	Phase 1|Phase 2
DC02280	TQB2825	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02280	TQB2825	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02280	TQB2825	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1
DC02280	TQB2825	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 2
DC02281	TQB2858	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 1|Phase 2
DC02281	TQB2858	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02281	TQB2858	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02282	TQB2868	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02283	TQB2930	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02284	TQB2934	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02285	TST005	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02286	Ubamatamab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 1|Phase 2
DC02287	Vanucizumab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02287	Vanucizumab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02288	Vepsitamab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 1
DC02288	Vepsitamab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 1
DC02288	Vepsitamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 1
DC02289	Vibecotamab	BsAb	FD00019	Hematologic Malignancies	Hematologic Malignancy	Phase 1
DC02289	Vibecotamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 2
DC02289	Vibecotamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 2
DC02290	Vixtimotamab	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02290	Vixtimotamab	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02290	Vixtimotamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02291	Volrustomig	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC02291	Volrustomig	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02291	Volrustomig	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 3
DC02291	Volrustomig	BsAb	FD00040	Soft Tissue Sarcoma	Other Cancer	Phase 1
DC02291	Volrustomig	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 2
DC02292	Voxalatamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02293	VP301	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02293	VP301	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02293	VP301	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02294	Vudalimab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02294	Vudalimab	BsAb	FD00018	Head and Neck Cancer	Head and Neck Cancer	Phase 2
DC02294	Vudalimab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02294	Vudalimab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02294	Vudalimab	BsAb	FD00034	Ovarian Cancer	Ovarian Cancer	Phase 2
DC02294	Vudalimab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC02295	WVT078	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02296	Xentuzumab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 1
DC02296	Xentuzumab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02296	Xentuzumab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 1
DC02297	XmAb18968	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02297	XmAb18968	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02298	XmAb24306	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02298	XmAb24306	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02299	XmAb808	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 1
DC02300	XmAb819	BsAb	FD00020	Kidney Cancer	Kidney Cancer	Phase 1
DC02301	Y101D	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02302	Y150	BsAb	FD00030	Myeloma	Hematologic Malignancy	Phase 1
DC02303	Zanidatamab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02303	Zanidatamab	BsAb	FD00011	Colorectal Cancer	Colorectal Cancer	Phase 2
DC02303	Zanidatamab	BsAb	FD00014	Esophageal Cancer	Esophageal Cancer	Phase 3
DC02303	Zanidatamab	BsAb	FD00022	Liver Cancer	Liver Cancer	Phase 2
DC02303	Zanidatamab	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
DC02303	Zanidatamab	BsAb	FD00041	Stomach Cancer	Stomach Cancer	Phase 3
DC02304	Zanidatamab Zovodotin	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02305	Zenocutuzumab	BsAb	FD00007	Breast Cancer	Breast Cancer	Phase 2
DC02305	Zenocutuzumab	BsAb	FD00023	Lung Cancer	Lung Cancer	Phase 2
DC02305	Zenocutuzumab	BsAb	FD00035	Pancreatic Cancer	Pancreatic Cancer	Phase 2
DC02305	Zenocutuzumab	BsAb	FD00038	Prostate Cancer	Prostate Cancer	Phase 2
DC02306	Zeripatamig	BsAb	FD00021	Leukemia	Hematologic Malignancy	Phase 1
DC02306	Zeripatamig	BsAb	FD00024	Lymphoma	Hematologic Malignancy	Phase 1
DC02307	ZGGS15	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1
DC02308	ZGGS18	BsAb	FD00033	Other Cancer	Other Cancer	Phase 1|Phase 2
